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Funding Race as Biology: The Relevance
of “Race” in Medical Research
Taunya Lovell Banks*
I.

INTRODUCTION: ‘DEM BONES, ‘DEM BONES, ‘DEM
“BLACK” BONES

In 1940 the State of North Carolina classified my friend as
“colored” despite her “white skin, blue eyes, [and] curling blond
hair.” 1 She—like her parents, grandparents, and many other
black Americans—is often mistaken for white. 2 Sixty years
later when she went for a bone densitometry test—a must for
postmenopausal women—the technician asked her to fill out a
form that asked her race. Surprised, she asked why. The
technician explained that “since the bones of black people are
different than the bones of white people, the doctor needed this
information to interpret the scan correctly.” 3
The radiologist who analyzed my friend’s bone scan
acknowledged that there is a debate within the radiology
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1. Judy Scales-Trent, Bones Essay 1 (Nov. 7, 2008) (unpublished
manuscript) (on file with author). In 1940 under the North Carolina State
Constitution and the state anti-miscegenation statute a “negro” or “person of
negro descent” was someone “of negro descent to the third generation,
inclusive,” in other words, a “person who has one-eighth [or more] negro blood
in his veins.” State v. Miller, 29 S.E.2d 751, 752 (N.C. 1944). See also N.C.
CONST. art. XIV, § 8 (unenforceable in 1967); N.C. GEN. STAT. § 51-3 (1943).
2. See generally JUDY SCALES-TRENT, NOTES OF A WHITE BLACK WOMAN:
RACE, COLOR, COMMUNITY 2 (1995); GREGORY HOWARD WILLIAMS, LIFE ON
THE COLOR LINE: THE TRUE STORY OF A WHITE BOY WHO DISCOVERED HE
WAS BLACK (1996).
3. Scales-Trent, supra note 1, at 1.
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community about the scientific validity of interpreting an X-ray
through the lens of race. 4 But, he claimed, it is impossible to
interpret the bone scan without factoring in race because the
machines that analyze the bone scan can only produce an
analysis if the race of the person being analyzed is included. 5
The doctor could not explain how the x-ray machine defined
“race,” replying that the definitions “were created by the
companies that built the machines.” 6
My friend asked if there was any way she could get more
helpful advice about the condition of her bones. 7 The radiologist
thought for a moment, then suggested that perhaps my friend
should have her bone densitometry test performed twice, once
as “white,” then as “black.” 8 The condition of her bones, he told
her, would lie somewhere between the two results. 9 However,
my friend concluded that “one-half of a fantasy definition of
‘white’ plus one-half of a fantasy definition of ‘black’ will only
yield one whole fantasy: it will not provide a sound medical
diagnosis.” 10 Thus she marked “black” or “African American”
because that had always been her legal and social identity. 11 So
what did the results really tell her doctor?
For years my friend taught and wrote about the social
construction of race and knew that her doctor’s explanation
about the use of race as a biological term by the radiology
community was flawed. 12 She found it reminiscent of the World
War II era when the Nazis kept “separate blood banks for
‘Jewish blood’ and ‘Aryan blood,’ [and] American blood banks
were separating ‘white blood’ and ‘black blood’.” 13 The United
States has a long and continuing history of “unconscionable
medical research” involving black Americans. 14
4. Id. at 2. For further discussion regarding this debate see Anne FaustoSterling, The Bare Bones of Race, 38 SOC. STUD. SCI. 657, 659 (2008).
5. Scales-Trent, supra note 1, at 2.
6. Id.
7. Id.
8. Id.
9. Id.
10. Id. at 3.
11. Telephone conversation with Professor Judy Scales-Trent, Professor
Emerita at The University at Buffalo Law School (Sept. 20, 2010).
12. Scales-Trent, supra note 1, at 1–3.
13. Id. at 2.
14. HARRIET A. WASHINGTON, MEDICAL APARTHEID: THE DARK HISTORY
OF MEDICAL EXPERIMENTATION ON BLACK AMERICANS FROM COLONIAL TIMES
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In 1950 the United Nations Educational, Scientific and
Cultural Organization (UNESCO), mindful of race-science’s
dark and not so distant history, 15 drafted a statement on the
use of race in modern science. 16 This statement, developed by
an esteemed group of anthropologists, psychologists, and
sociologists, concludes: “[f]or all practical social purposes ‘race’
is not so much a biological phenomenon as a [damaging] social
myth.” 17 Today most scientists agree that race and ethnicity
(ethno-race) classifications are the result of social and political
conditions, as opposed to biological differences. 18 There is,
however, disagreement about the scientific validity of these
categories. 19

TO THE PRESENT

2 (2006).
15. Raj Bhopal, Is Research into Ethnicity and Health Racist, Unsound, or
Important Science?, 314 BRIT. MED. J. 1751 (1997); Lundy Braun et al., Racial
Categories in Medical Practice: How Useful Are They?, 4 PLOS MED. 1423
(2007); Charis Thompson, Race Science, THEORY, CULTURE & SOC’Y, May
2006, at 547; WASHINGTON, supra note 14.
16. The Race Question in Modern Science: The Race Concept Result of an
Inquiry, UNITED NATIONS EDUC., SCIENTIFIC AND CULTURAL ORG. (1952),
available
at
http://unesdoc.unesco.org/images/0007/000733/073351eo.pdf.
UNESCO acted in response to “a resolution . . . adopted by the United Nations
Economic and Social
Council . . . asking UNESCO . . . to consider the
desirability of initiating and recommending the general adoption of a
programme of disseminating scientific facts designed to remove what is
generally known as racial prejudice.” Id. at 6 (punctuation omitted).
17. Id. at 101. A half of century later the Human Genome Project seemed
to confirm the scientific irrelevance of race, finding “high levels of genetic
similarity within the human species.” Dorothy E. Roberts, Legal Constraints
on the Use of Race in Biomedical Research: Toward a Social Justice
Framework, 34 J.L. MED. & ETHICS 526, 526 (2006). For a discussion of the
Human Genome Project see All About the Human Genome Project, NAT’L
HUMAN GENOME RESEARCH PROJECT, http://www.genome.gov/10001772 (last
visited Dec. 7, 2010). As a result, some scholars speculated that genetic
differences “would replace race as the preeminent means of grouping people
for scientific purposes.” Roberts, supra, at 526. But genetic differences did not
replace racial categories, instead, debates about the scientific validity of race
reemerged in connection with genomic, biomedical and biotechnology research.
Id.
18. See, e.g., Timothy Caulfield et al., Race and Ancestry in Biomedical
Research: Exploring the Challenges, 1 GENOME MED 8.1, 8.2 (2009); Roberts,
supra note 17, at 526.
19. See generally JENNY REARDON, RACE TO THE FINISH: IDENTITY AND
GOVERNANCE IN AN AGE OF GENOMICS 4 (2005); S.O.Y. Keita & Rick A.
Kittles, The Persistence of Racial Thinking and the Myth of Racial Divergence,
99 AM. ANTHROPOLOGIST 534 (1997); Dorothy Roberts, What’s Wrong with
Race-Based Medicine?: Genes, Drugs, and Health Disparities, 12 MINN. J.L.
SCI. & TECH. 1, 2–7 (2011). Because self-identified ethno-race often serves as a
“poor proxy for underlying genetic relatedness,” many researchers have begun
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Even though an increasing number of scientists believe
that too often ethno-race is used as a surrogate for various
socioeconomic and environmental factors, 20 for most of the late
twentieth century social science and medical researchers
continued to use ethno-race in a biological context. 21
Nevertheless, there are times when ethno-racial
designations have value in medical research. As one scholar
writes, “using race as a social category” to study the impact of
racism on health and access to medical care is critical to
eliminating health inequities based on race. 22 But, she cautions
that using race as a biological category can reflect and reinforce
racial stratification as well as racist notions of inherent human
difference. 23 Several commentators call this phenomenon the
reification of race, where the social concept of race is
transformed “into a specific, definite, concrete, and now
presumably genetic category which can feed back into
preexisting lay understandings of racial difference.” 24
Congress regulates a great deal of medical research with
the promise of federal monies. The relevance of ethno-race in
medical research has been heightened by two decades of federal
legislation, most notably the U.S. National Institutes of Health
Revitalization Act of 1993 (Revitalization Act), which contains
initiatives on minority health. 25 The Revitalization Act
requires that, among other things, women and “minority
using DNA estimates of ancestry (ancestral DNA) in genetic-association
research. Caulfield et al., supra note 18, at 8.2. The major genetic variations,
however, correspond to the major continents, giving rise to the same racial
distinctions the use of ancestry seeks to avoid. Id. at 8.2.
20. Otis W. Brawley & Harold P. Freeman, Race and Outcomes: Is This
the End of the Beginning for Minority Health Research?, 91 J. NAT’L CANCER
INST. 1908, 1908 (1999).
21. See Braun, supra note 15, at 1424.
22. Roberts, supra note 17, at 527.
23. Id.
24. OSAGIE K. OBASOGIE, CENTER FOR GENETICS & SOC’Y, PLAYING THE
GENE CARD? A REPORT ON RACE AND HUMAN BIOTECHNOLOGY 5 (2009),
available
at
http://geneticsandsociety.org/downloads/complete_PTGC.pdf.
Jonathan Kahn argues that the approval of BiDil signals that “powerful
federal agencies have acknowledged the legitimacy of using race as a marker
for biological difference.” Jonathan Kahn, How a Drug Becomes “Ethnic”: Law,
Commerce, and the Production of Racial Categories in Medicine, 4 YALE J.
HEALTH POL’Y & ETHICS 1, 33 (2004). Anthropologist Alan Goodman
characterizes this type of research as a “‘comeback’ in ‘racialized notions of
biology.’” Id.
25. See 42 U.S.C. § 201 (1993); see also Roberts, supra note 17, at 527.
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groups” be included in all intramural and extramural National
Institutes of Health (NIH) funded biomedical and behavioral
research. 26 Since most biomedical research is funding driven,
minority health initiatives may, by promoting greater racial
diversity among clinical subjects, generate a medical research
market that unintentionally promotes the misuse of ethnorace. 27
Some commentators express concern about the resulting
re-emergence of race in biomedical studies, but most concede
that legal challenges to the current medical research practices
may not be the most effective means of quickly minimizing or
remedying the problem. 28 Further, litigation may actually
discourage needed and valid race related studies. 29 Courts,
searching for ethno-racial medical biases, may become
overzealous and act in ways that actually thwart positive racerelated medical research, such as inquiries into access to care
and equal treatment. 30 In addition, federally funded biomedical
research that uses race inappropriately is socially harmful
because, as I will discuss throughout this article, the practice
tends to perpetuate the disputed notion that race is biological,
and it evokes the historical baggage associated with racescience. Thus, due to the probable ineffectiveness of legal
challenges, some government regulation or oversight is
warranted where public funds are involved.
Only a handful of legal scholars have addressed the
dangers inherent in the uncritical use of ethno-race in medical
studies and the debates within the biomedical research
community about the use of ethno-race in research. 31 None, I
26. Karen H. Rothenberg, Gender Matters: Implications for Clinical
Research and Women’s Health Care, 32 HOUS. L. REV. 1201, 1231 (1996).
27. See Roberts, supra note 17, at 529.
28. For a discussion of this point see Osagie K. Obasogie, Beyond Best
Practices: Strict Scrutiny as a Regulatory Model for Race-Specific Medicines,
36 J.L. MED. & ETHICS 491, 494–95 (2008) (discussing the strengths and
weaknesses of applying a constitutional law based “strict scrutiny” approach
to the use of race-specific labels in the pharmaceutical field).
29. Erik Lillquist & Charles A. Sullivan, The Law and Genetics of Racial
Profiling in Medicine, 39 HARV. C.R.-C.L. L. REV. 391, 466–68 (2004) (noting
the potential loss of certain beneficial race-based medical research).
30. Id. at 466.
31. See Kahn, supra note 24 (arguing for tighter Food and Drug
Administration (FDA) regulation of race specific drugs); Lillquist & Sullivan,
supra note 29 (exploring the constitutionality of using race in scientific
research); Obasogie, supra note 28 (focusing on the role of the FDA in
determining whether to approve race specific medicine); Roberts, supra note
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contend, provide a comprehensive overview of the issue nor
propose an effective remedy. While there is a general consensus
that race and other social classifications influence health,
“there is little agreement about why or how [ethno-] race
matters, how best to study its effects and how to translate and
communicate research results from racially stratified
studies.” 32
Legal scholar Dorothy Roberts posits that “[f]ederal
funding agencies’ control over the funding for biomedical
research is a powerful basis for restricting the use of race” in
medical studies. 33 She also offers a few general suggestions for
how funding restrictions might operate. 34 In this article I build
on Roberts’ initial suggestions by offering more specific
recommendations for federal funding restrictions on biomedical
research that uses ethno-racial categories.
This article proceeds from the assumption that there are
few clear instances, other than perhaps access to health care or
measuring equality in medical treatment, where the use of
ethno-race in medical research is appropriate. Even in those
limited situations the justification for using ethno-race, how
the ethno-racial categories are defined, and the method for
assigning ethno-race warrant close scrutiny and oversight,
especially when these studies are funded with federal money.
In the next section, this article explains the scientific basis for
that assertion. First, it explores the debates within the medical
community about the connection between race and biology in
biomedicine. Then it examines literature on race-related stress
to determine whether this might be an instance where ethnoracial labels help explain health outcomes, and argues that
17 (proposing a “social justice framework” designed to encourage the
appropriate use of race in medical research); Michael D. Ruel, Using Race in
Clinical Research to Develop Tailored Medications Is the FDA Encouraging
Discrimination or Eliminating Traditional Disparities in Health Care for
African Americans?, 27 J. LEGAL MED. 225 (2006) (arguing that while using
race in medical trials is acceptable, the government needs to develop rules on
this based on scientific evidence to make sure discrimination does not occur).
32. Caulfield et al., supra note 18, at 8.2 (concluding that “[r]esearch that
simultaneously assesses both genetic and environmental contributions to
disease risk, drug response and other health-related variation, and that
deliberately puts such findings in the context of self-identified race, is urgently
needed,” or else race will continue to be used, problematically, in biomedical
research).
33. Roberts, supra note 17, at 529.
34. Id. at 530–33.
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guidelines or regulation are needed.
The third section of this article examines two sets of
guidelines on the use of ethno-race in biomedical research:
guidelines adopted by high impact medical journals, and
federal guidelines on the use of ethno-race in federally funded
biomedical research. Finding these measures inadequate, this
article argues that the only way to quickly change research
behavior in this area is through greater regulation and
oversight of federal medical research grants. More stringent
government regulation and oversight of federally funded
biomedical research grants that use ethno-race may trigger
changes in the medical culture faster than litigation.
In the fourth section this article proposes a regulatory
scheme that offers a standard to measure the appropriateness
of ethno-race in applications for federally funded biomedical
research that will cause both researchers and grant reviewers
to give more thought to how and why ethno-race is used in
research protocols. This article concedes that this proposal is
only a first step, and acknowledges that meaningful progress
also requires strong and effective measures designed to change
how biology is taught in undergraduate, graduate, and
professional schools. But without a change in the medical
culture, another generation of researchers and health care
providers will be trained to think about ethno-racial differences
inappropriately.
Before effective remedies for the problem described can be
discussed, it is important to clarify both the meaning and use of
the term “race” in scientific discussions. The next section of this
paper looks at debates within the scientific community about
the meaning of ethno-racial labels.
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II. “IF RACE IS THE ANSWER, WHAT IS THE
QUESTION?” 35 DEBATES ON THE USE OF RACE IN
RESEARCH
A. LINKS BETWEEN RACE AND BIOLOGY
1. Contemporary Debates
In the late nineteenth century “scientists [named and]
ranked races on their biological and social worth.” 36 Much of
the resulting research from this era is “racist, unethical, and
ineffective.” 37 Even more troubling, race-science was used to
justify slavery, anti-immigration policies, and imperialism. 38
Although race-science was abandoned by the mid-twentieth
century, a few researchers in the 1990s expressed concerns that
ethno-race was still being misused in contemporary biomedical
research. 39 This section looks at the debates within research
communities about the use of racial categories in biomedical
research.
Most contemporary scientists concede that nineteenth
century stereotypes of race and racial variations probably
reflect the superficial understanding of the relationship
between ethno-race and biological difference or lack of

35. Taken from the title of an article about the misuse of “race” as
explaining persistent health outcome disparities among racial and ethnic
groups in the United States. Nancy Krieger, If “Race” is the Answer, What is
the Question?—On “Race,” Racism, and Health: A Social Epidemiologist’s
Perspective, IS RACE REAL?, SOC. SCI. RES. COUNCIL (June 7, 2006),
http://raceandgenomics.ssrc.org/Krieger/.
36. Bhopal, supra note 15, at 1751.
37. Id.
38. Id.
39. See Trevor A. Sheldon & Hilda Parker, Race and Ethnicity in Health
Research, 14 J. PUB. HEALTH MED. 104, 104 (1992). The authors write that
“[h]ealth research appears to be reflecting the process of ‘racialization’ . . .
whereby the idea of race or ethnicity is increasingly being introduced to help
define or give meaning to the population [being studied]” and argue for more
thought and care in the use of race and ethnicity as health research variables.
Their article was part of a debate within the United Kingdom about the use
and misuse of race and ethnicity. See, e.g., R.S. Bhopal et al., Inappropriate
Use of the Term ‘Asian’: An Obstacle to Ethnicity and Health Research, 13 J.
PUB. HEALTH MED. 244 (1991); Jenny L. Donovan, Ethnicity and Health: A
Research Review, 19 SOC. SCI. MED. 663, 668 (1984) (concluding that studying
particular diseases or illnesses affecting ethnic groups tends to place blame on
subalterns rather than attributing these health problems to economic and
social structures).
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difference held by scientists in that era. 40 The debate
continues, however, over whether race has any legitimacy as a
scientific concept, and more fundamentally, whether and how
to study human biological diversity. Biologist Marcus Feldman
and his co-authors write: “[t]he issue of whether race is a
biologically useful or even meaningful concept when applied to
humans in a medical context is controversial.” 41 But the
authors claim that there really is “no contradiction” between
the bodies of evidence on each side of the debate. This is
because the issue conflates two different questions: whether
distinguishable DNA sequences related to “major geographical
origin” exist and whether “most genetic diversity occurs within
groups.” 42 The answer to both questions, according to the
authors, is yes. 43 Therefore, those who argue that race is
relevant present evidence linking race to geographic origin, and
those who argue that race is irrelevant present evidence of
genetic diversity within racial groups.
This debate does not contest the use of socially constructed
ethno-racial categories to measure differences in access to
health care, delivery of health care, and equal medical
treatment. Studies such as these measure social attitudes of
health care providers. Therefore, they are distinguishable from
studies that use ethno-race to explain biological differences in
disease or medical outcomes unrelated to social disparities in
health care. 44 Nevertheless, as my friend’s bone density test
experience illustrates, the undifferentiated connection between
race and biology persists in America.

40. See, e.g., Bhopal supra note 15, at 1752; Braun, supra note 15, at
1724; Thompson, supra note 15, at 547.
41. Marcus W. Feldman et al., A Genetic Melting-Pot, 424 NATURE 374,
374 (2003). The authors explain:
Race as a biological concept has had a variety of meanings. In the
taxonomic literature, a race is any distinguishable type within a
species . . . . In 1937, Theodosius Dobzhansky introduced the idea of
geographical races—populations of species that differ in the
frequencies of one or more genetic variants . . . . The classical
definition of race . . . is based on phenotypes such as skin colour,
facial features and hair . . . . An underlying assumption is that all of
these defining features . . . are characteristic of the genome in
general.
Id.
42. Id.
43. Id.
44. See supra notes 1–13 and accompanying text.
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2. SICKLE CELL DISEASE AND RACE
Discussing the connection between race and genetics,
Feldman and his co-authors argue that ancestral geographical
origin can be useful in diagnosis and treatment, but that a
person’s racial classification, whether self-identified or
assigned, “is both too broad and too narrow a definition of
ancestry to be biologically useful.” 45 They specifically cite
sickle-cell disease, widely thought by Americans to be a trait
connected to African ancestry, but which in reality is
“characteristic of ancient ancestry in a geographic region where
malaria was endemic.” 46 Since individuals with the sickle cell
trait do not get malaria, researchers now believe that the trait
is a genetic mutation that developed as a protective measure in
areas around the world where malaria is common. 47
Malaria most often found in Africa, once was common
around the Mediterranean as well. 48 Thus, the trait also is
found in “Portuguese, Spaniards, French Corsicans,
Sardinians, Sicilians, mainland Italians, Greeks, Turks and
Cypriots.” 49 Today, sickle-cell disease is most common in
Middle Eastern countries like Lebanon, Israel, Saudi Arabia,
Kuwait and Yemen and Near Eastern countries like India and

45. Feldman et al., supra note 41, at 374.
46. Id.; see also Anthony C. Allison, Two Lessons From the Interface of
Genetics and Medicine, 166 GENETICS SOC’Y AM. 1591, 1592 (2004) (finding,
when testing his hypothesis that sickle cell was related to malaria, that the
“distribution, involving diverse populations, supported the belief that an
environmental factor, malaria transmission, was the principle determinant of
high sickle-cell frequencies”); Donovan, supra note 39, at 665 (“Sickle-cell
anemia first occurred in Britain when immigrants arrived from Africa and the
Caribbean where the disease had developed to give partial immunity to
endemic malaria.”).
47. See, e.g., Allison, supra note 46, at 1592–93; Blood Diseases, U. MD.
MED. CENTER, http://www.umm.edu/blood/sickle.htm (last updated Jan. 30,
2008).
48. Blood Diseases, supra note 47.
49. McKinley Health Center, Sickle Cell Disease, U. OF ILL. AT URBANA(Mar.
7,
2007),
CHAMPAIGN
http://www.mckinley.illinois.edu/handouts/sickle_cell_disease.html. According
to the National Heart Lung and Blood Institute, sickle cell anemia is “most
common in people whose families come from Africa, South or Central America
(especially Panama), Caribbean islands, Mediterranean countries (such as
Turkey, Greece, and Italy), India, and Saudi Arabia.” See also Who Is at Risk
for Sickle Cell Anemia?, NAT’L HEART LUNG AND BLOOD INST.,
http://www.nhlbi.nih.gov/health/dci/Diseases/Sca/SCA_WhoIsAtRisk.html (last
visited Dec. 7, 2010).
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Sri Lanka. 50
The tendency in the United States to link sickle-cell
disease to black Americans stems from the fact that black
Americans are more likely than any other ethno-racial group in
the country to have the sickle-cell trait. 51 A closer examination
of the evidence indicates, however, that geography, rather than
race, factors into the trait’s prevalence. 52 Most black Americans
are descendants of enslaved Africans from West and Central
Africa where the disease is most common. 53 It follows,
therefore, that in the United States, African ancestry is a factor
in the prevalence of sickle-cell among black Americans.
Although most states routinely test all newborns for the trait, 54
public health officials may continue to link sickle-cell to race
and target only black Americans for outreach. 55 This results
from an incorrect assumption that the prevalence of sickle cell
among black Americans is due to a connection between biology
and race. 56
As Feldman and his co-authors caution, other variables
like migration and mating may result in new populations, thus,
“[a] person classified as ‘black’ or ‘Hispanic’ by social
convention could have any mixture of ancestries, as defined by

50. Who Is at Risk for Sickle Cell Anemia?, supra note 49.
51. Eight percent of African Americans have the sickle cell trait. DIV. OF
BLOOD DISEASES AND RESOURCES, NAT’L INST. OF HEALTH, THE MANAGEMENT
SICKLE CELL DISEASE 15 (4th ed. 2002), available at
OF
http://www.nhlbi.nih.gov/health/prof/blood/sickle/sc_mngt.pdf; Learning About
Sickle Cell Disease, NAT’L HUMAN GENOME RESEARCH INSTITUTE, available at
http://www.genome.gov/page.cfm?pageID=10001219 (last visited Dec. 16,
2010) (“In the United States, sickle cell disease is most prevalent among
African Americans. About one in 12 African Americans and about one in 100
Hispanic Americans carry the sickle cell trait . . . .”).
52. See generally Allison, supra note 46.
53. Who Is at Risk for Sickle Cell Anemia?, supra note 49. According to the
University of Maryland Medical Center, “[s]ickle cell disease primarily affects
those of African descent and Hispanics of Caribbean ancestry, but the trait
has also been found in those with Middle Eastern, Indian, Latin American,
Native American, and Mediterranean heritage.” U. MD. MED. CTR., supra note
47.
54. U. MD. MED. CTR., supra note 47.
55. See Braun et al., supra note 15, at 1425–26 (arguing that “[i]n the case
of sickle cell disease, it would be best to work from symptoms rather than
racial assumptions, and to enquire about geographic ancestry since sickle cell
is more prevalent in populations from the Mediterranean region, sub-Saharan
Africa, and the Indian subcontinent”).
56. Id. at 1426.
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continent of origin.” 57 Physicians might fail to test individuals
for sickle cell disease because they are not classified as black. If
the disease remains undiagnosed and untreated, severe
medical consequences, or even death, may result. Thus, it may
be more important to know a patient’s family medical history
than race, since a person who identifies as black or white may
have grandparents or great grandparents whose ancestral
geographical origins include areas where the trait or disease is
common. 58
3. BONE DENSITY AND RACE
Similarly, some researchers continue to argue that there is
a correlation between race and biology in bone density.
According to the first sentence of an article in a 2008 issue of
the Journal of Nutrition: “Diet and race are important
predictors of areal bone mineral density (aBMD) and fracture
risk.” 59 The introductory sentence reads like a general fact; it is
not footnoted. 60 Under the subheading, Racial differences in
bone density, the authors write:
African American men and women have higher aBMD than other
racial groups, including American white, Asian, Hispanic, and Native
Americans. Such differences are attenuated but still generally persist
when aBMD data are adjusted for weight, bone size, and other

57. Feldman et al., supra note 41, at 374 (arguing that social race
“provides information about the social circumstances and lifestyle of
patients”). However, even this description ignores the heterogeneity and class
differences within populations raced as black in America.
58. “A ‘black’ person walking into a Boston, Massachusetts clinic could
easily be the child of a recent immigrant from Ethiopia or Brazil who has a
genetic makeup as well as cultural and environmental exposures that differ
significantly from the descendents of 19th century US [sic] slaves from the
western coast of Africa.” Braun et al., supra note 15, at 1426. Another
researcher wrote: “In the case of sickle cell disease, it would be best to work
from symptoms rather than racial assumptions, and to enquire about
geographic ancestry.” Id. Thus Feldman et al. conclude that a better approach
is to identify “all contributions to a patient’s ancestry” when “diagnosing and
treating disease with genetic influences.” Feldman et al., supra note 41, at
374.
59. Marcella D. Walker et al., Race and Diet Interactions in the
Acquisition, Maintenance, and Loss of Bone, 138 J. NUTRITION 1256S, 1256S
(2008).
60. There is, however, reason to doubt these “important predictors.” See
Marc C. Hochberg, Racial Differences in Bone Strength, 118 TRANSACTIONS
AM. CLIN. & CLIMATOLOGICAL ASS’N 305, 308–10 (2007) (discussing several
studies that support the claim that whites have lower bone mineral density
than blacks).

2011]

FUNDING RACE AS BIOLOGY

583

covariates, such as physical activity, calcium intake, smoking, and
alcohol use. 61

The authors base these statements on earlier studies of
fracture risk and bone density among various ethnic groups. 62
These earlier studies are the basis for the different
measurement standards for determining bone density that
were applied to my friend.
The same year as the aforementioned study, biologist and
feminist scholar Anne Fausto-Sterling asked whether accepted
studies on bone density that report notable differences based on
race really reflect racial differences and if so, what this means
“biologically and socially.” 63 Fausto-Sterling looked at a sample
of published research to determine how researchers defined
race in studies examining claims about the relationship
between race and bones. She notes that many early papers
discussing bone density cite to Mildred Trotter’s work in the
1960s and 1970s, 64 but that new technology prompted a shift
away from Trotter’s methods to large-scale studies. 65 The
change in methodology, however, was not accompanied by a
shift in thought about the use of race as a factor. FaustoSterling takes issue with these modern studies, arguing they
reveal “profound inconsistencies in the definitions and modes of
ascertainment of racial categories, a lack of theory about why
race might be an important study variable, and no clear
rationale about how race might exert effects on bone biology.” 66
Yet papers addressing bone density into the early twentyfirst century still began with the presumption that race-based
differences in bone density are “incontrovertibly established.” 67

61. Walker et al., supra note 59, at 1256S–57S.
62. Id.
63. Fausto-Sterling, supra note 4, at 659. Fausto-Sterling’s question
applies to biomedical, biotechnological, and genomic research generally, but
this article only focuses on biomedical or medical research.
64. Trotter was a well-known anatomist and anthropologist whose
professional career spanned from 1922 until 1984. “Her research led to
discoveries about the structure and distribution of hair, and the growth, racial
and sexual differences, and aging of the human skeleton. Additionally, her
work in skeletal biology led to the creation of formulas to estimate stature
based on the lengths of long leg bones.” Missouri Women in the Health
Sciences: Mildred Trotter, WASH. U. ST. LOUIS SCH. OF MEDICINE,
http://beckerexhibits.wustl.edu/mowihsp/bios/trotter.htm (last visited Dec. 7,
2010).
65. Fausto-Sterling, supra note 4, at 661.
66. Id. at 662.
67. Id.
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As such, Fausto-Sterling argues based on her research, these
studies are suspect because the scientists used race
uncritically. 68 She is not alone in her criticism, which applies
equally to other medical research studies.
B. DEBUNKING THE LINK BETWEEN RACE AND BIOLOGY
In the late 1990s, American social scientists spoke out
strongly against connecting race with biology. After studying
the issue, the Executive Committee of the American
Anthropological Association (AAA) concluded: “present-day
inequalities between so-called ‘racial’ groups are not
consequences of their biological inheritance but products of
historical and contemporary social, economic, educational, and
political circumstances.” 69 The AAA’s statement reflects the
concerns expressed two years earlier by British social
researchers attempting to fashion a framework for the

68. She writes that “the social [notion of racial distinction] produces the
biological in a system of constant feedback between body and social
experience.” Id. at 658 (emphasis in original). The accepted scientific
assumption for bone disease in adults is that white and Asian women are at
highest risk, followed by Hispanic women, then by white and Asian men, then
Hispanic men, then black men. Black women have rates similar to white men.
Id. Further, as my colleague Amanda Pustilnik commented to me, even if
these findings were real, their significance is open to question. If what matters
is fracture risk, and fracture risk results from current bone density—not
percentage of bone loss from baseline—then a starting point would seem
irrelevant. But if a starting point mattered, then it seems that the doctor
would want to compare that patient’s current results to her own, individual
scan taken at Time 1. There must be all kinds of starting point bone density
differences, depending on childhood nutrition, individual genetics, childhood
sports, etc. So not only is the “racial” dimension of this claim questionable, the
whole starting point position seems to be a pure nonsense dimension.
69. Statement on “Race”, AM. ANTHROPOLOGICAL ASS’N (May 17, 1998),
http://www.aaanet.org/stmts/racepp.htm. A few years earlier the AAA adopted
a resolution that read in part: “differentiating species into biologically defined
‘races’ has proven meaningless and unscientific as a way of explaining
variation.” Statement on “Race” and Intelligence, AM. ANTHROPOLOGICAL
ASS’N (Dec. 1994), http://www.aaanet.org/stmts/race.htm. Almost a decade
later, social scientist Troy Duster repeated this concern about the “current
understandings of the relationship between race and disease . . . [and the
increasing reliance on] genetically oriented biomedical scientists . . . to define
and identify causes for a wide-ranging set of problems—from alcoholism to
gender and racial health disparities.” Fausto-Sterling, supra note 4, at 657
(citing the 2005 inaugural address of Troy Duster, Comparative Perspectives
and Competing Explanations: Taking on the Newly Configured Reductionist
Challenge to Sociology, AM. SOC. REV 1 (2006)).
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“classification of ethnic or cultural groups.” 70 They argued that
when medical researchers use ethno-racial categories, under
the belief that ethno-race explains the differences in disease
patterns, the onus should be on the researchers to clearly
establish the biological correlation. 71 Unlike the British model,
the later AAA statement contains no qualifiers; no
circumstances when the use of ethno-racial classifications is
warranted. This absolutist approach is a sticking point with
some researchers who believe that there are instances where
ethno-racial categories can function as both an ascriptive factor
(“to identify the causal mechanisms involved and to select
clinical interventions”) 72 and as a descriptive factor (“to
document progress in the health status of populations”). 73
Other researchers argue that ethno-race is only relevant in
biomedical research as a descriptor. But even in this instance
researchers have yet to agree on how to define ethno-racial
categories.
Two articles that appeared in the September 2007 issue of
PLoS Medicine, a peer-reviewed journal published by the
Public Library of Science, illustrate the ongoing debate in the
medical research community about the use of ethno-race. The
first, written by Lundy Braun (with Fausto-Sterling and other
co-authors), begins by drawing the distinction between the
importance of the descriptive use of racial and ethnic
categories, as negative health outcomes differ among racial and
ethnic groups, and the widespread ascriptive use of U.S. census
ethno-racial categories in biomedical research. 74 The misuse of
ethno-racial categories in the latter instance, Braun et al.
argue, is reinforced by the National Institutes of Health’s (NIH)
funding regulations designed to ensure greater inclusion of

70. Kwame McKenzie, Describing Race, Ethnicity, and Culture in Medical
Research, 312 BRIT. MED. J. 1054, 1054 (1996) (also noting that the U.K.
adopted categories used by the Office of Population Censuses and Surveys for
use in the 1991 census). See also Mike Pringle & Ian Rothera, Practicality of
Recording Patient Ethnicity in General Practice: Descriptive Intervention
Study and Attitude Survey, 312 BRIT. MED. J. 1080, 1082 (1996) (ethnicity
should be self-defined and is of questionable value in general practice).
71. See McKenzie, supra note 70.
72. George T.H. Ellison et al., Racial Categories in Medicine: A Failure of
Evidence-Based Practice?, 4 PLOS MED. 1434, 1434 (2007).
73. Braun et al., supra note 15, at 1427. See also Ellison et al., supra note
72, at 1424 (defining the descriptive use as “to identify differences in health
and health care that warrant further investigation and intervention”).
74. Braun et al., supra note 15, at 1423.
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racial/ethnic minorities in clinical research. 75 These regulations
use the racial and ethnic categories as defined by the U.S.
Office of Management and Budget (OMB)’s Directive No. 15 76
to measure inclusion rates. The result is “poorly defined racial
categories [that become] reified in biomedical research
practices.” 77
Consider, for example, the classification problem that
might arise if a clinical protocol calls for the physician to
identify the race of a man who immigrated to the United States
at a young age and self-identifies as Cape Verdean. 78 “The
large Cape Verdean population in New England resists any
simple categorization. The inhabitants are the descendents of
Portuguese colonists, former slaves, explorers, and sailors of

75. Id. at 1424 (noting that the Institute of Medicine’s (IOM) definition of
race, is an example of how “granting agencies’ regulations do little to clarify
the extent to which racial and ethnic categories are intended to capture
biological, cultural, or social dimensions of human diversity”).
76. NIH Policy and Guidelines on the Inclusion of Women and Minorities
as Subjects in Clinical Research, U.S. DEP’T HEALTH & HUM. SERVS. (Oct.
2001),
http://grants.nih.gov/grants/funding/women_min/guidelines_amended_10_200
1.htm. For a discussion of this point, see Braun et al., supra note 15, at 1424.
The American Anthropological Association describes OMB Directive 15 as
follows:
The Statistical Policy Division, Office of Information and Regulatory
Affairs, of the Office of Management and Budget (OMB) determines
federal standards for the reporting of “racial” and “ethnic” statistics.
In this capacity, OMB promulgated Directive 15: Race and Ethnic
Standards for Federal Statistics and Administrative Reporting in
May, 1977, to standardize the collection of racial and ethnic
information among federal agencies and to include data on persons of
Hispanic origins, as required by Congress. Directive 15 is used in the
collection of information on “racial” and “ethnic” populations not only
by federal agencies, but also, to be consistent with national
information, by researchers, business, and industry as well.
Directive 15 described four races (i.e., American Indian or
Alaskan Native, Asian or Pacific Islander, Black, and White) and two
ethnic backgrounds (of Hispanic origin and not of Hispanic origin).
The Directive’s categories allowed collection of more detailed
information as long as it could be aggregated to the specified
categories.
American Anthropological Association Response to OMB Directive 15: Race
and Ethnic Standards for Federal Statistics and Administrative Reporting,
AM.
ANTHROPOLOGICAL
ASS’N
(Sept.
1997),
http://www.aaanet.org/gvt/ombdraft.htm [hereinafter Response to OMB
Directive 15].
77. Braun et al., supra note 15, at 1423–24.
78. Id. at 1424.
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various nationalities.” 79 Given this reality, is the subject black?
Is the subject “now African American or should [the physician]
consider [the subject’s] health needs from the perspective of his
immigrant status? The data on response to therapy seem to
suggest that hypertension in blacks is somehow special,
implying a separate genetic factor for blacks.” 80
Given the historical misuse of ethno-racial categories in
ways that perpetuate notions about racial inferiority, Braun et
al. ask whether ethno-race is a useful factor to consider in
determining medical care. 81 Their concern is that physicians,
relying on race-based biomedical research, will make diagnoses
or risk assessments and treatment decisions based on a
person’s race rather than using a procedure that considers
factors like environment, family history, stress, and other
socioeconomic contributors to health disparities. 82 Braun et al.
argue that because racial categories are deceptively simple they
conceal diverse internal populations. For example, a person
with black, white, and Native American ancestors may selfidentify as black, as would a recent immigrant from Ethiopia.
Rather than work from racial assumptions, some grounded in
geographic ancestry, Braun et al., like Feldman and his coauthors, argue that researchers should focus on individual
symptoms. 83 Otherwise, “[o]nce race is presumed . . . [c]linical
clues can become invisible.” 84
To counter this troubling trend, Braun et al. recommend
educating medical researchers and practitioners about cultural
competency, historical misuse of racial categories, current
debates about the validity of ethno-race in medicine, limits of
racial categorization in the medical context, population race
79. Id.
80. Id. (explaining that “African Americans suffer at rates 3.5 times those
of Nigerians living in Africa, although African Americans experience only 0.75
the rates of Germans in Germany. Which category matters more for [a]
patient, country of origin or social status in the adopted nation?”) (internal
citations omitted).
81. Id. at 1424–25.
82. Id.
83. Id. at 1426. Braun et al. also discuss the idea of cultural competency,
espoused in some quarters, which encourages clinicians to “familiarize
themselves with the history of the particular communities they serve.”
Conceding that the approach may have some benefits (“[it] brings greater
attention to the attitudes and behaviors that patients may bring to the clinical
encounter”), they also believe it brings the danger that the clinician may see
patients as “types” rather than individuals. Id.
84. Id. at 1425–26.
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versus individual race, and geographical genetic variation. 85
While they acknowledge the need for “an international
consensus” on the use of ethno-racial categories in science, they
argue for more immediate action by the NIH in reevaluating its
policies on racial categorization and by medical schools in
improving their instruction on race in medicine. 86
Medical anthropologist George T.H. Ellison and his coauthors recognize the challenges to instituting more precise
attributive factors as well as the need to distinguish between
the descriptive use of ethno-racial categories, and the ascriptive
use of such categories. 87 Ellison and his co-authors, however,
find Braun and her co-authors’ proposals problematic. First,
they point to a “lack of consensus about what race and ethnicity
mean and how these [categories] should be operationalised.” 88
Second, while researchers know that ethno-racial categories are
inaccurate, Ellison et al. adopt a “pragmatic” approach to NIH
requirements designed to insure greater representation of
ethno-racial groups in research studies. 89 Ellison et al., like
Braun et al., worry that the crude ethno-racial categories that
NIH uses to monitor inclusion of racial and ethnic minorities in
clinical trials and to describe differences in health care and
health outcomes actually may be harmful. They warn that NIH
policies that use OMB-like ethno-racial categories for these
purposes may undermine efforts to ascertain “more precise

85. Id. at 1426–27.
86. Id. at 1427. Braun et al. ends by restating the distinction drawn by
anthropologist Michael Montoya between using ethno-race descriptively and
ascriptively. Id.
87. Ellison et al., supra note 72, at 1435.
88. Id. at 1434. Ellison et al. concede this lack of consensus means that
“researchers and practitioners may conflate the utility of racial and ethnic
categories for sampling diverse study populations with their ability to identify
and address aetiological variation therein.” Id. (internal citations omitted).
Ellison et al. argue that Braun’s proposal “would require unprecedented
agreement amongst a comprehensive international consortium of funders and
providers” about the use of ethno-racial categories. Id. at 1436.
89. Id. Ellison et al. concede that “[t]he use of crude socio-political
categories of race and ethnicity to describe variation in health risks and health
needs, and to attribute these differences to innate genotypic and socio-cultural
factors, has a long and discredited history.” Id. at 1435. In an effort to avoid
stigmatizing particular racial or ethnic groups, some researchers “adopt the
more socially acceptable term ‘ethnicity’ in preference to ‘race,’” while other
researchers adopt “crude socio-political classifications” such as the OMB
categories. Id.
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attributive evidence.” 90 Ellison and his co-authors propose that
ethno-racial categories be used only as “descriptive variables in
different scientific, clinical, and social contexts.” 91 They argue
that other genetic, cultural, or structural markers need to be
identified and developed to provide a more precise causal
connection of the disparities in health and health care. 92
C. STRESS AND BLACK AMERICANS: DOES SOCIAL RACE HAVE A
BIOLOGICAL COMPONENT?
The foregoing discussion does not squarely address another
question, whether there is validity in doing research on
different race-based outcomes that flow from social and
environmental factors. Arguably, there could be a biological yet
socially created reality to race differences in health. This
section explores what might be required to make such research
useful.
Medical experts agree that stress can affect the onset,
progression, and severity of illness, and that racism and racerelated stress have an impact on health. 93 Stress literature
90. Id. While racial and ethnic categories are helpful for descriptive
purposes, Ellison et al. argue that “researchers and clinicians do need to be
encouraged to use more specific attributive markers of genotype, culture, and
structural disadvantage wherever appropriate.” They argue that the use of
racial and ethnic categories in describing differences in health risks and
outcomes might result in the same crude categories being misattributed as the
cause of health differences. Id.
91. Id.
92. Id.
93. David R. Williams & Selina A. Mohammed, Discrimination and Racial
Disparities in Health: Evidence and Needed Research, 32 J. BEHAV. MED. 20,
27 (2009) (explaining how, according to stress literature, stress affects the
onset, progression, and severity of illness, and describing several health
conditions that may be affected by stress, including five physiological
categories where stress has been shown to affect symptoms (neuroendocrine
system, cardiovascular system, gastrointestinal system, pain sensitivity and
chronic pain, and immune function)). Williams and Mohammed also encourage
future research that “focus[es] its attention on those outcomes where prior
research has documented that stress in general is linked to health.” Id. at 38.
See also Elizabeth Brondolo et al., Race, Racism and Health: Disparities,
Mechanisms, and Interventions, 32 J. BEHAV. MED. 1, 3 (2009) (noting that
exposure to racism, in any form, may initiate a series of “acute and enduring
changes in cognition, affect, behavior, and psychophysiological responses”);
Yin Paradies, A Systematic Review of Empirical Research on Self-Reported
Racism and Health, 35 INT’L J. EPIDEMIOLOGY 888, 893 (2006) (reporting that
a group of twenty-six studies revealed a significant association between selfreported racism and 44% of certain health outcomes, including blood pressure,
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suggests that acute and chronic experiences with racism have
different effects on illness and disease. 94 The strongest
association has been found between racism and negative
mental health outcomes. 95 Some studies have also found a
relationship between racism and certain physical health risks,
conditions, or behaviors. 96
Overall, the associations between racism and health vary
among different ethno-racial groups, with black Americans
experiencing the strongest associations and white Americans
experiencing
the
weakest
associations,
even
when
socioeconomic factors are taken into account. 97 It is important
to note, however, that whites generally experience less racism
than non-whites, which may explain the different race-related

birth weight, BMI/obesity, and mortality; 36% of all negative health outcomes
were significantly associated with racism).
94. Williams & Mohammed, supra note 93, at 33.
95. Id. at 22; Paradies, supra note 93, at 892.
96. See Paradies, supra note 93, at 893 (finding that 44% of negative
physical health outcomes were “significantly associated with self-reported
racism” based on measured physical health outcomes including blood pressure,
birth weight, BMI/obesity, and mortality); Shawn O. Utsey et al., Effect of
Ethnic Group Membership on Ethnic Identity, Race-Related Stress and Quality
of Life, 8 CULTURAL DIVERSITY & ETHNIC MINORITY PSYCHOL. 366, 368 (2002)
[hereinafter Effect of Ethnic Group Membership] (discussing the effects of racerelated stress response on the immune, neuroendocrine, and cardiovascular
systems); Shawn O. Utsey et al., Race-Related Stress, Quality of Life
Indicators, and Life Satisfaction Among Elderly African Americans, 8
CULTURAL DIVERSITY & ETHNIC MINORITY PSYCHOL. 224, 225 (2002)
[hereinafter Race-Related Stress] (explaining that racism has been associated
with stress-related diseases such as hypertension, coronary heart disease, and
cancer, as well as psychological ailments including depression).
97. See Deidre Franklin-Jackson & Robert T. Carter, The Relationships
Between Race-Related Stress, Racial Identity, and Mental Health for Black
Americans, 33 J. BLACK PSYCHOL. 5, 6 (2007) (noting studies that linked
racism to various psychological symptoms and the hypothesis among scholars
and researchers that Blacks may experience racism as a chronic or life event
stressor); Hope Landrine et al., Conceptualizing and Measuring Ethnic
Discrimination in Health Research, 29 J. BEHAV. MED. 79, 79 (2006) (stating
that “[m]inorities who perceive and report individual-level ethnic
discrimination have more physical and psychiatric symptoms and problematic
health behaviors than their White and than their no-discrimination minority
cohorts”); Chalsa M. Loo et al., Measuring Exposure to Racism: Development
and Validation of a Race-Related Stressor Scale (RRSS) for Asian American
Vietnam Veterans, 13 PSYCHOL. ASSESSMENT 503, 525 (2001); Utsey et al.,
Effect of Ethnic Group Membership, supra note 96, at 366–67 (noting that
African Americans have higher measures of race-related stress than Whites
and Asians); .
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stress levels. 98 Nevertheless, several comparative studies
“found that self-reported racism was related to ill-health for
African Americans and Latinos/as, but not [w]hites.” 99 Other
studies found inverse associations, leading one researcher to
conclude that “the association between self-reported racism and
health-related outcomes for studies that included [w]hite
participants is comparable with the findings of studies
involving other ethnic/racial groups.” 100
While factors like intensity, frequency, and duration of the
stressor can affect negative outcomes, 101 further research is
needed to determine whether racism is analogous to other
stressors, 102 whether there is an association between mature
stages of racial identity and less race-related stress, 103 and
whether racial identity may modify the association between
self-reported racism and ill health. 104 Research also is needed
to determine the additional long-term effects of race-related
stress. 105 Further illustrating the complexity of race in
biomedicine,
researchers
acknowledge
problems
in
conceptualizing and measuring racism. 106
While early stress studies focused on health disparities
between different ethno-racial groups, new research suggests
that there are also differences within each racial group. 107
Thus, some commentators suggest that future research should
consider both the differences between and within groups to
determine whether ethnicity is “a moderating factor in the

98. Paradies, supra note 93, at 891.
99. Id.
100. Id. at 893.
101. Williams & Mohammed, supra note 93, at 35–38.
102. Id. at 33.
103. Franklin-Jackson & Carter, supra note 97, at 18–19.
104. Paradies, supra note 93, at 893.
105. Utsey et al., Race-Related Stress, supra note 96, at 231 (stressing that
professionals need to understand how racism as a chronic stressor affects
quality of life). While coping strategies and socialization are specified by Utsey
et al. as potential medicating factors, in another article, Utsey mentions a
positive association between ethnic identity and quality of life. See Utsey et
al., Effect of Ethnic Group Membership, supra note 96, at 374.
106. See Brondolo et al., supra note 93, at 3 (“One of the most challenging
issues in the study of racism has been its conceptualization and
measurement . . . . Therefore, studies contrasting the prevalence and health
effects of different categories of racism/ethnic discrimination are also needed,
and this will require alterations in approaches to conceptualizing and
measuring racism.”).
107. Id.
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relationship of psychosocial stressors, such as racism, to health
outcomes.” 108 These commentators also suggest that future
studies focus on different categories of racism (cultural,
institutional, individual) and the varying contexts in which
racism occurs. 109
The stress studies literature suggests that under some
circumstances self-identified ethno-race, even though socially
constructed, may be valid as a measure in scientific research.
But even here, simplistic ethno-racial categories are inadequate
measures. Following early studies that found “perceived racial
discrimination contributed significantly to psychiatric
symptoms among African Americans,” some researchers looked
for a reliable way to measure perceived racial
discrimination. 110 Each of these measures acknowledges that
stress resulting in physical and mental illness is not triggered
by social race alone, but is heavily linked to individual
perceptions of race, the extent of racial and cultural selfidentification, and how individuals experience and process
racist or discriminatory behavior. Further, the stress response
to racism and discrimination is associated with psychological
and physiological reactions such as anxiety and paranoia, and
the physiological responses primarily involve the immune,
108. Id. Examples of psychophysiological reactivity cited were cortisol,
blood pressure, and heart rate responses. Id. at 4.
109. Id. at 4. For additional commentary on the need for future research in
this area, see David R. Williams et al., The Concept of Race and Health Status
in America, 109 PUB. HEALTH REP. 26 (1994) (discussing the potential effects
of racism and racial discrimination on health outcomes, particularly stress and
hypertension, and the need for further research).
110. Loo et al., supra note 97, at 503–04. A proposed Race-Related Stressor
Scale (RRSS) created three categories of race-related stressors: (1) racial
prejudice and stigmatization (direct experiences of perceived discrimination or
exclusion), (2) bicultural identification and conflict (identifying with a racial or
ethnic minority and culture), and (3) racist environment (witnessing racist or
discriminatory behavior). Id. at 504–05. The study applied this measure to
Asian American Vietnam veterans finding that exposure to one, or a
combination of, the three categories above contribute to Post Traumatic Stress
Disorder (PTSD) and general psychiatric symptoms. Id. at 514–15. Another
research group, concerned about the failure of early stress studies to measure
the frequency and appraisal of stressful events offered another measure, the
General Ethnic Discrimination Scale (GEDS) that looks at both frequency and
appraisal of discriminatory events across all ethnic groups based on the stress
coping model. Landrine et al., supra note 97, at 80–81. Still another research
group used the Index of Race-Related Stress (IRRS) that in its “brief version”
measures cultural, institutional, and individual racism. Utsey et al., Effect of
Ethnic Group Membership, supra note 96, at 370.
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neuroendocrine, and cardiovascular systems. 111
Ethnic group membership was found to have a statistically
significant effect on race-related stress, ethnic identity score,
and quality of life scores. African Americans had higher scores
for race-related stress, ethnic identity, and the psychological
well-being subscale of the quality of life measure. The results
further indicated that racial identity and cultural racism stress
both significantly predicted qualities of life. As might be
expected, cultural racism was inversely related to quality of
life. Notably, one study indicated that ethnic identity was the
best predictor of quality of life, which implies that ethnic
identity is related to psychological and physical health. 112
Thus, studies on race-related stress that only take race into
account would be, according to these articles, fatally flawed.
Future studies need to account for a range of other factors that
can affect how race-related stress impacts individuals. Such
factors should include socialization, coping strategies, cultural
identity, individual perception, types of racism, environmental
factors, and traditional stressors.
As the race-related stress studies suggest, descriptive race
in its crudest form may overlook important differences within
categories. Even if stress is a circumstance where ascriptive
ethno-race may contribute to a medical outcome, it is important
to look at other contributing factors. Thus, more thoughtful use
of ethno-race as either a descriptor or ascriptor should be the
goal of any biomedical research-related guideline or regulation.
In their critiques of race’s relevance in biomedical research,
Braun, Ellison, and their co-authors acknowledge the potential
influence that biomedical journals have on the use of ethnoracial categories. They point out that journals approach this
question from one of three perspectives. Some journals accept
self-identified race or ethnicity as an acceptable proxy for
genetic makeup, others state that race should not be used in
genetic research because of the genetic variation within selfidentified populations, and still others adopt a middle position
whereby race can be used to ensure diversity in studies, but not
as a proxy for genetic variation. 113 Braun et al. cite a recent
111. Utsey et al., Effect of Ethnic Group Membership, supra note 96, at 368.
Previous studies found that the psychological effects of stress include anxiety
and paranoia, and the physiological responses primarily involve the immune,
neuroendocrine, and cardiovascular system. Id.
112. Id. at 372–75.
113. Braun et al., supra note 15, at 1424.
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study finding that “commonly used ethnic labels are both
insufficient and inaccurate representations of the inferred
genetic clusters, and that drug-metabolizing profiles . . . differ
significantly among the clusters.” 114 Ellison et al. advocate
advancing their proposal through biomedical journals, noting,
however, that some journals are resistant to guidelines, and
that the guidelines have not significantly affected the content
of the journals that do have them. 115 Recently a few highimpact medical journals stepped into this debate. The next
section examines and critiques both medical journal and
federal guidelines on the use of ethno-race in biomedical
research.
III. GUIDELINES ON RACE AND ETHNICITY
A. JOURNAL GUIDELINES
Some experts agree with Braun and Ellison about the role
high impact scientific journals can play in discouraging the
misuse of race in medical research, but they disagree about the
goal and focus of journal guidelines. Stacie Geller et al., for
example, argue that these journals need to adapt their editorial
guidelines to reinforce the importance of greater compliance
with federal guidelines aimed at promoting more diversity
among clinical study participants. 116 Fausto-Sterling, on the
other hand, advocates even stronger measures. She argues that

114. Id. at 1424 (internal citations omitted).
115. Ellison et al., supra note 72, at 1436. According to the authors, “648
journals signed up to the [sic] International Committee of Medical Journal
Editors’ Uniform Requirements for Manuscripts Submitted to Biomedical
Journals: Writing and Editing for Biomedical Publication, which recommend
that ‘When [sic] authors use variables such as race or ethnicity, they should
define how they measured the variables and justify their relevance.’” Id.
Ellison et al. call for an international consensus in the biomedical community
to support guidelines that (1) improve racial and ethnic categories as
descriptive factors; (2) advocate for the inclusion of specific genotypical,
cultural, and structural attributive factors; and (3) “generat[e] evidence from
population studies of racial and ethnic groups that can be used to improve the
care of individual patients from these groups across different social and
clinical contexts.” Id.
116. See Stacie E. Geller et al., Adherence to Federal Guidelines for
Reporting of Sex and Race/Ethnicity in Clinical Trials, 15 J. WOMEN’S
HEALTH 1123, 1130–31 (2006). The authors also argue that funding agencies
must engage in greater scrutiny of the clinical trials they support to ensure
equitable enrollment among gender and race/ethnicity. Id.
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editors of scientific journals and those who review articles for
these journals should require that researchers define and
justify their use of racial categories, especially since other
factors like socioeconomic status, geography, and individual life
cycle may be better predictors of specific disease patterns. 117
To date, three major English language scientific academic
publications, the British Medical Journal, Nature Genetics and
the Journal of the American Medical Association, have
announced guidelines on the use of race and ethnicity in
medical research. With the exception of Nature Genetics, these
journal guidelines are aspirational, not mandatory. A fourth
journal, the New England Journal of Medicine, entertained a
debate on the subject but adopted no guidelines. Most
guidelines advocate for increased clarity in why ethno-race is
being considered, the rationale behind the ethno-racial
groupings, and the method of subject assignment. This section
critiques these guidelines to determine whether any contain
useful restrictions Congress might adopt to discourage the
inappropriate use of ethno-race in federally funded bio-medical
research.
The Journal of the American Medical Association (JAMA)
is the only journal to expressly advocate the use of selfidentified race in biomedical research. 118 According to Margaret
Winkler, Deputy Editor of JAMA, the guidelines elaborate on
and clarify the published guidelines of the International
Committee of Medical Journal Editors (CMJE) that advise
authors who use ethno-racial variables to “define how they
measured the variables and justify their relevance.” 119 The
JAMA guidelines add that “authors should describe who
designated race and/or ethnicity for an individual” and also
note that “self-designation generally is preferred.” 120 Rather
than discourage the use of ethno-racial labels in research, the
JAMA guidelines support subject self-identification of ethnoracial identity that, as mentioned previously and discussed
117. Fausto-Sterling, supra note 4, at 670.
118. Margaret A. Winkler, Editorial, Measuring Race and Ethnicity: Why
and How?, 292 J. AM. MED. ASS’N 1612, 1614 (2004).
119. Id. (citing INTERNATIONAL COMMITTEE OF MEDICAL JOURNAL
EDITORS, UNIFORM REQUIREMENTS FOR MANUSCRIPTS SUBMITTED TO
BIOMEDICAL JOURNALS: WRITING AND EDITING FOR BIOMEDICAL PUBLICATION,
sec. IV.A.6.a (updated Nov. 2003), http://www.icmje.org/#prepare). The CMJE
guideline statement emphasizes the need for clarity in racial categorization.
Id.
120. Id. (emphasis added).
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below, is a poor proxy for genetic variation. 121
One example of why self-identification of ethno-racial
identity is a poor proxy for genetic variation lies in the fact that
a subject’s self-identified ethno-racial status may be different
from that individual’s bio-geographic ancestry based “on a
range of historical, cultural and sociopolitical factors.” 122 My
friend, for example, self-identifies as black (remote African
ancestry), while her bio-geographic ancestry may more strongly
correspond to her remote European ancestry. Thus, selfidentification as a method to assign ethno-racial categories
(and sometimes inappropriately infer genetic makeup) is
limited because it may only provide a partial view of the
individual’s geographic genetic ancestry. 123 Nevertheless, selfidentified race and bio-geographic ancestry are important in
studying health disparities. 124
Second, the JAMA guidelines state that “[a]uthors should
indicate whether the options for [racial and ethnic] designation
were closed or open.” 125 Winkler notes that while open-ended
options potentially provide a more accurate description of
individual ethno-racial identity, open-ended self-reported
ethno-race is difficult to categorize for research purposes. 126
Knowing, for example, that a clinical subject self-identifies as
having Hawaiian, Chinese, English, and Korean ancestry helps
establish the diversity of enrollees, but outside of a study of
populations in Hawaii this level of self-identification will result
in too small a sample group to provide researchers with useful
information. Unfortunately, Winkler offers no solutions for
dealing with problematic open-ended options.
The JAMA guidelines further suggest that researchers
should make ethno-racial coding in studies more “transparent”
by disclosing the options for racial categories used by
researchers, how these options were established, and what
121. See Caulfield et al., supra note 18, at 8.2. For a discussion of this
point, see supra footnotes 17, 28, 84 and accompanying text.
122. Sandra Soo-Jin Lee et al., The Ethics of Characterizing Difference:
Guiding Principles on Using Racial Categories in Human Genetics, 9 GENOME
BIOLOGY 404, 404.2 (2008) (Statement 3).
123. Id. at 404.2.
124. Id.
125. Winkler, supra note 118, at 1614. The guideline continues: “If the
options were closed, authors are asked to provide what the options were,
whether categories were combined, and, if so, how.” Id.
126. Id.
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subcategories are included in the study. 127 Thus, this guideline,
which seems to favor closed option ethno-racial designations for
coding purposes, undercuts the first and supposed primary
guideline goal, clarity in racial categorization.
Clarity in ethno-racial designations is also relevant in
monitoring who has access to clinical studies, a point addressed
in part by the last JAMA guideline, which states that authors
should justify why they believe ethno-race is “relevant to the
particular study.” 128 The goal of this guideline is to encourage
researchers to more critically consider the relevance of ethnorace as factors in their study 129 or, in other words, to analyze
whether the ascriptive use of ethno-race is appropriate. Thus,
JAMA encourages researchers to directly measure other social
and environmental factors as causes. 130
By not renouncing the use of race as a proxy for genetic
similarity, the JAMA guidelines, while an improvement, only
hint at the potential for misuse of ethno-racial labels in
research. Under the guideline, race is a permissible proxy for
other difficult to measure variables, so long as the rationale for
doing so is clearly stated. 131 Yet Winkler cites no examples of
situations where race would be an acceptable substitute for
these difficult to measure and unspecified variables, a
troublesome omission.
Further, Winkler’s reasoning seems circular. She concedes
that race is a social construct with little or no scientific value
but argues that ethno-racial self-identification may have some
unspecified value in biomedical research. Because the JAMA
guidelines provide little real guidance researchers are likely to
continue following old familiar patterns, relying on older
studies that used race inappropriately.
As mentioned earlier, the British Medical Journal (BMJ)
was the first high impact medical journal to publish guidelines
127. Id.
128. Id. (noting that the authors should state their rationale if they use
race or ethnicity as proxies for unknown, or hard to measure variables and
providing the following examples of social and environmental factors that
should be measured directly: “socioeconomic status, education, urban vs. rural
location, or income region by zip code”).
129. Id.
130. Id. (instructing the researcher to “determine whether an outcome is
truly related to ethno-race (as defined by the study) or to other factors with a
closer relationship to the causal pathway”).
131. Id. (identifying variables such as socioeconomic status, education,
urban versus rural locations, or income region by ZIP code).
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on the use of ethno-race in biomedical research. The journal
offers three major guidelines with the first two meant to
encourage authors to explain “the logic behind their ‘ethnic’
groupings.” 132 First, the journal urges authors “to use accurate
descriptions” when employing ethno-racial terminology. 133 In
explaining the need for these guidelines, BMJ discusses how
ethno-race terminology is subject to culture, political debates
and imperatives. 134 Since ethno-race terms are forever
changing, the journal reasons, authors should provide
descriptions with racial terminology so that future researchers
will be able to more reliably compare past results to future
ones. 135
Secondly, BMJ announced that, henceforth, racial or ethnic
descriptions should reference the method behind these
groupings. 136 Thus, BMJ encourages specific descriptions of
ethno-racial categories, as well as a notation of how the
groupings were assigned. As an example of the first two
guidelines, BMJ used the ethno-racial self-identified label
“black Caribbean” instead of “black.” 137
The third guideline provides that any ethno-racial
“[c]ategorisation . . . should relate to the type of hypothesis
under investigation.” 138 BMJ notes that “race has limited
biological validity,” 139 thus categories based on genetic makeup, for example, should be used ascriptively in studies
assessing health risks, whereas ethno-racial categories may be
more helpful descriptively in studies assessing health services.
If researchers do not know which, among race, ethnicity, or
culture, will be the most powerful determinant of the outcome,
BMJ advises them to measure each factor. 140 Thus, BMJ
encourages researchers to collect a range of information,
including genetic differences, self-assigned ethnicity, observerassigned ethnicity, country or area of birth, years in country of

132. Editorial, Ethnicity, Race, and Culture: Guidelines for Research,
Audit, and Publications, 312 BRIT. MED. J. 1094 (1996).
133. Id.
134. Id.
135. Id.
136. Id.
137. Id.
138. Id.
139. Id.
140. Id.
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residence, and religion. 141 These guidelines aim at ensuring
that biomedical research is more comparable in the future.142
Whereas JAMA and BMJ published their guidelines
hoping that authors would try to follow them, only one journal,
Nature Genetics, stated that their guidelines are mandatory. 143
In an editorial describing the new guidelines, Nature Genetics
discussed how the 2000 U.S. Census, in an effort to address the
nation’s increasing diversity, included an option for “Other
Race.” 144 The editorial explains that this option allows
individuals to self-select more than one ethno-racial category
and will create “63 possible permutations.” 145 The editorial goes
on to acknowledge that in most scientific communities, “race” is
not a scientific term. 146 Nature Genetics then states, however,
that ethno-race may be a valid variable in scientific studies as a
proxy for discriminatory experiences, diet, or other
environmental factors, but it should not be used as a substitute
for measurable parameters such as genetic variation or
differences in metabolism. 147
Nature Genetics’ goal in mandating journal guidelines is to
“raise awareness and inspire more rigorous design of genetic
and epidemiological studies.” 148 Going forward, Nature Genetics
will require authors to explain the reason for their use of
specific ethno-racial groups and how that classification was
achieved. 149 The hope is that these guidelines will encourage
researchers to find ways to improve the health of populations

141. Id. (explaining that, to determine genetic differences, research should
use “relevant genetically determined polymorphism,” that “nationally agreed
guidelines” should be used to determine self-assigned ethnicity” thereby
“enabling comparability with census data,” that “observer-assigned ethnicity”
should use “OPCS or other national census categorisation or the researchers’
own logically argued categories,” and “country or area of birth” should be
determined by using “the subject’s own, or parents’ and grandparents’ if
applicable”).
142. Id.
143. Editorial, Census, Race and Science, 24 NATURE GENETICS 97, 98
(2000).
144. Id. at 97.
145. Id. at 97.
146. Id. at 97–98 (referencing the AAA’s 1997 recommendation that the
U.S. government stop using race in collection of data because race is a social
not a scientific concept).
147. Id. at 98.
148. Id.
149. Id.
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without using ethno-race as a “pseudo-biological” variable. 150
In 2001, the New England Journal of Medicine (NEJM)
entertained a debate about the use of ethno-race in biomedical
research, but stopped short of imposing guidelines. Instead, it
published a powerful editorial by Dr. Robert S. Schwartz, a
deputy editor of NEJM, criticizing the uncritical use of race in
research. 151 He also encourages all journals to adopt the Nature
Genetics guidelines on the use of racial and ethnic categories in
medical research. 152
In his editorial, Dr. Schwartz cites two articles published
in the same issue that use race inappropriately. 153 Like others,
he believes that any study using ethno-racial categories “should
begin with a plausible, clearly defined, and testable hypothesis”
which considers the relevance of these categories. 154 A better
approach, according to Dr. Schwartz, is to focus on genetic
variations, rather than ethno-racial differences. 155 He reasons
that the genetic similarities across ethno-race categories
reported by the human genome project “should force an end to
medical research that is arbitrarily based on race.” 156
Reflecting the ongoing debate about the use of race in
biomedical research, Dr. Schwartz’s editorial was countered by
another editorial “praising” the use of race in medical
research. 157 The debate in NEJM continued in 2003 when the
journal published another pair of articles for and against the

150. Id.
151. Robert S. Schwartz, Racial Profiling in Medical Research, 344 NEW
ENG. J. MED. 1392, 1392–93 (2001).
152. Id. at 1393.
153. Id. at 1392 (citing Clyde W. Yancy et al., Race and the Response to
Adrenergic Blockade with Carvedilol in Patients with Chronic Heart Failure,
344 NEW. ENG. J. MED. 1358–65 (2001) (reporting that carvedilol, a beta
blocker, has a similar benefit in blacks and nonblacks with chronic heart
failure) and Derek V. Exner et al., Lesser Response to Angiotensin-ConvertingEnzyme Inhibitor Therapy in Black as Compared with White Patients with Left
Ventricular Dysfunction, 344 N. ENGL. J. MED. 1351, 1351–57 (2001) (claiming
that enalapril, an angiotension-converting-enzyme inhibitor, is more effective
when used in whites with left ventricular dysfunction than in blacks)).
154. Id. at 1393.
155. Id. at 1393.
156. Id. at 1393. See sources cited supra note 17.
157. Lillquist & Sullivan, supra note 29, at 394 (citing Alastair J.J. Wood,
Racial Differences in the Response to Drugs—Pointers to Genetic Differences,
344 NEW ENG. J. MED. 1393 (2001) (favoring the use of race)).
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uncritical use of race in research. 158 The question of NEJM
guidelines in this area remains unresolved to this day.
The journal guidelines discussed above are generally
similar to the recommended guidelines announced in 2008 by a
multi-disciplinary group from Stanford University (the
Stanford Group 159 ). 160 Although the Stanford Group’s
guidelines regarding the use of ethno-racial categories were
developed for use in research exploring “human genetic
variation,” 161 they seem equally applicable to biomedical
research. In some respects, the Nature Genetics guidelines are
almost identical to provisions of the Stanford Group guidelines.
Nature Genetics, for example, requires authors to “explain why
they make use of particular ethnic groups or populations, and
how classification was achieved.” 162 Similarly, the Stanford
Group encourages researchers to “describe how individual
samples are assigned category labels, [and] to explain why
samples with such labels were included in the study.” 163
Unfortunately, however, the Nature Genetics guidelines, like
the guidelines proposed by JAMA and BMJ, fail to address the
myriad of other issues surrounding racial categorization
presented in the Stanford Group model.
More specifically, the Stanford Group recommends that
researchers, when considering whether to use ethno-race as a
factor in a study, ask themselves three questions: (1) why race
or ethnicity is relevant to the study, (2) how race or ethnicity is
to be determined, and (3) whether the ethno-racial categories
are variables in the research. 164 Thus rather than construct a
158. Id. (referencing Esteban González Burchard et al., The Importance of
Race and Ethnic Background in Biomedical Research and Clinical Practice,
348 NEW ENG. J. MED. 1170 (2003) (favoring the use of race) and Richard S.
Copper et al., Race and Genomics, 348 NEW ENG. J. MED. 1166 (2003)
(opposing the use of race)).
159. The Stanford Group consists of “faculty from the humanities, social
sciences, life sciences, law, and medicine.” Lee et al., supra note 122, at 404.1.
160. Compare, e.g., Census, Race and Science, supra note 143, at 98
(requiring authors to “explain why they make use of particular ethnic groups
or populations, and how classification was achieved”) with Lee et al., supra
note 122, at 404.2 (encouraging researchers to “describe how individual
samples are assigned category labels, [and] to explain why samples with such
labels were included in the study”).
161. Lee et al., supra note 122, at 404.1.
162. Editorial, supra note 143, at 98.
163. Lee et al., supra note 122, at 404.2.
164. Id. (suggesting that in order to design a research protocol that
minimizes the “use of science for racial stereotyping,” researchers can “assess
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study of cancer rates among ethno-racial groups, the Stanford
Group argues that it might be more appropriate to construct a
study of cancer rates based on age or gender that also records
the ethno-race of subjects. Other researchers also agree with
the Stanford Group about the importance of education in
remedying the problem. 165 Dr. Schwartz, for example, writes
that educating academics and researchers about “the fallacy of
race as a scientific concept”, is an especially important
component in preventing misuse of race in medical research. 166
BMJ’s guidelines have had mixed results. BMJ published
sixteen post-guideline studies between 2000 and 2009 that
considered race or ethnicity. 167 Four studies clearly meet the

the purpose and impact of using racial and ethnic categories in their research
and investigate whether alternative approaches would be appropriate”). But
see Dale E. Hammerschmidt, It’s as Simple as Black and White! Race and
Ethnicity as Categorical Variables, 133 J. LABORATORY & CLINICAL MED. 10,
11 (1999) (suggesting that race should be treated the same as other categorical
variables by: identifying what about race may be important to the study
[which often leads to a more appropriate socioeconomic variable]; establishing
criteria for subject assignment, and applying such criteria consistently, in an
organized manner; and emphasizing clarity in the method of subject
assignment and awareness of the potential misuse of study findings).
165. Schwartz, supra note 151, at 1393; see also Lee et al., supra note 122,
at 404.3 (arguing for the genetics curriculum to include a history of the use of
science to further racist theories and policies).
166. Schwartz, supra note 151, at 1392.
167. Imelda Balchin et al., Racial Variation in the Association Between
Gestational Age and Perinatal Mortality: Prospective Study, 334 BRIT. MED. J.
833 (2007); J. Boydell et al., Incidence of Schizophrenia in Ethnic Minorities in
London: Ecological Study into Interactions with Environment, 323 BRIT. MED.
J. 1336 (2001); Annie Britton et al., Does Access To Cardiac Investigation and
Treatment Contribute to Social and Ethnic Differences in Coronary Heart
Disease? Whitehall II Prospective Cohort Study, 329 BRIT. MED. J. 318 (2004);
Francesco P. Cappuccio et al., Application of Framingham Risk Estimates to
Ethnic Minorities in United Kingdom and Implications for Primary Prevention
of Heart Disease in General Practice: Cross Sectional Population Based Study,
325 BRIT. MED. J. 1271 (2002); Desiree M.A. Choi et al., Ethnicity and
Prescription of Analgesia in an Accident and Emergency Department: Cross
Sectional Study, 320 BRIT. MED. J. 980 (2000); Gene Feder et al., Ethnic
Differences in Invasive Management of Coronary Disease: Prospective Cohort
Study of Patients Undergoing Angiography, 324 BRIT. MED. J. 511 (2002); Nick
Freemantle et al., What Factors Predict Differences in Infant and Perinatal
Mortality in Primary Care Trusts in England? A Prognostic Model, 339 BRIT.
MED. J. 2892 (2009); Julia Hippisley-Cox et al., Association of Deprivation,
Ethnicity, and Sex with Quality Indicators for Diabetes: Population Based
Survey of 53,000 Patients in Primary Care, 329 BRIT. MED. J. 1267 (2004)
[hereinafter Hippisley-Cox et al. I]; Julia Hippisley-Cox et al., Predicting Risk
of Type 2 Diabetes in England and Wales: Prospective Derivation and
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BMJ guidelines, 168 if the census categories provide adequate
description of the ethno-racial categories. 169 In five other
studies, it is unclear whether the first guideline recommending
the use of accurate ethno-racial descriptions is actually met.
Some articles provide no description whatsoever of the ethnoracial categories beyond the names of the categories
themselves. 170 Thus, while we know what is included in the
ethno-racial category (i.e., black includes black African, black
Caribbean, and mixed), the categories in the studies still use
the broad, non-descriptive terms (i.e., black, white, non-white,
and Asian) that the guidelines attempted to discourage.
The most difficult part of the BMJ guidelines is to discern
whether the ethno-racial categorization in these studies relates

Validation of QDScore, 338 BRIT. MED. J. b880 (2009) [hereinafter HippisleyCox et al. II]; Marian Knight et al., Inequalities in Maternal Health: National
Cohort Study of Ethnic Variation in Severe Maternal Morbidities, 338 BRIT.
MED. J. b542 (2009); Trevor W. Lambert et al., Characteristics of Consultants
Who Hold Distinction Awards in England and Wales: Database Analysis with
Particular Reference to Sex and Ethnicity, 328 BRIT. MED. J. 1347 (2004); Kath
Moser et al., Inequalities in Reported Use of Breast and Cervical Screening in
Great Britain: Analysis of Cross Sectional Survey Data, 338 BRIT. MED. J.
b2025 (2009); Sonia Saxena et al., Socioeconomic and Ethnic Group
Differences in Self Reported Health Status and Use of Health Services by
Children and Young People in England: Cross Sectional Study, 325 BRIT. MED.
J. 520 (2002); Jane Wardle et al., Development of Adiposity in Adolescence:
Five Year Longitudinal Study of an Ethnically and Socioeconomically Diverse
Sample of Young People in Britain, 332 BRIT. MED. J. 1130 (2006); Peter H.
Whincup et al., Early Evidence of Ethnic Differences in Cardiovascular Risk:
Cross Sectional Comparison of British South Asian and White Children, 324
BRIT. MED. J. 635 (2002); Katherine Woolf et al., Ethnic Stereotypes and the
Underachievement of UK Medical Students from Ethnic Minorities: Qualitative
Study, 337 BRIT. MED. J. a1220 (2008).
168. Hippisley-Cox et al. II, supra note 167; Knight et al., supra note 167;
Saxena et al., supra note 167; Woolf et al., supra note 167.
169. U.K. census categories are as follows: White (includes options for
British, Irish, or any other white background), mixed (includes options of
White and Black Caribbean, White and Black African, White and Asian, or
any other mixed background), Asian or Asian British (includes options for
Indian, Pakistani, Bangladeshi, any other Asian background), Black or Black
British (includes options for Caribbean, African, any other black background),
Chinese or other ethnic group (includes options for Chinese, or write-in for
other ethnic group). OFFICE FOR NAT’L STATISTICS, EXEC. OFFICE OF THE UK
STATISTICS AUTHORITY, CENSUS 2001 FORM: ENGLAND HOUSEHOLD FORM
(2001), available at http://www.statistics.gov.uk/census2001/pdfs/engh1.pdf.
170. Balchin et al., supra note 167; Boydell et al., supra note 167; Britton
et al., supra note 167; Cappuccio et al., supra note 167; Choi et al., supra note
167; Feder et al., supra note 167; Freemantle et al., supra note 167; HippisleyCox et al. I, supra note 167; Lambert et al., supra note 167; Moser et al., supra
note 167; Wardle et al., supra note 167; Whincup et al., supra note 167.
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to the type of hypothesis under investigation. According to the
guidelines, “race has little biological validity”; 171 therefore, if
the studies were looking for biological differences, they should
have used categories based on genetic variation, not race. If the
studies were merely looking for racial disparities in quality and
access to health care, or the impact of social and environmental
factors on health outcomes, then ethno-racial categories may be
appropriate. Several articles seemed to use race this way, 172
but a few articles seem to be looking for biological difference
and, therefore, used ethno-racial categories inappropriately. 173
Only one of four identified studies published in Nature
Genetics from 2000 to 2009 seems to meet the criteria
established by that journal. 174 Two of the three remaining
studies meet one of the two guidelines, but differ as to which
guideline was met. 175 The last study does not seem to meet
either guideline. 176 Thus, there is no real pattern as to how
authors use or disregard the Nature Genetics guidelines. 177
While all of the journal guideline statements mentioned
above are promising developments, without stringent oversight,
there is little incentive for researchers to change their
methodologies or thinking about ethno-race. Even mandatory

171. Ethnicity, Race, and Culture, supra note 132.
172. Boydell et al., supra note 167; Britton et al., supra note 167; Choi et
al., supra note 167; Feder et al, supra note 167; Freemantle et al., supra note
167; Hippisley-Cox et al. I, supra note 167; Hippisley-Cox et al. II, supra note
167; Knight et al., supra note 167; Lambert et al., supra note 167; Moser et al.,
supra note 167; Saxena et al., supra note 167; Woolf et al., supra note 167.
173. These studies seem to use ethno-race inappropriately: Cappuccio et al,
supra note 167; Whincup et al., supra note 167. It is unclear whether the
following studies use race inappropriately: Balchin et al., supra note 167;
Wardle et al, supra note 167.
174. John P.A. Ioannidis et al., ‘Racial’ Differences in Genetic Effects for
Complex Diseases, 36 NATURE GENETICS 1312 (2004).
175. Anna Helgadottir et al., A Variant of the Gene Encoding Leukotriene
A4 Hydrolase Confers Ethnicity-Specific Risk of Myocardial Infarction, 38
NATURE GENETICS 68 (2006); Richard S. Spielman et al., Common Genetic
Variants Account for Differences in Gene Expression Among Ethnic Groups, 39
NATURE GENETICS 226 (2007).
176. E.J. Parra et al., Implications of Correlations Between Skin Color and
Genetic Ancestry for Biomedical Research, 36 NATURE GENETICS S54 (2004).
177. Although the journal guidelines are intended for clinical studies, two
commentaries published in Nature Genetics seem to partially meet the
guidelines. See David B. Goldstein & Joel N. Hirschhorn, In Genetic Control of
Disease, Does ‘Race’ Matter?, 36 NATURE GENETICS 1243 (2004); Hua Tang,
Confronting Ethnicity-Specific Disease Risk, 38 NATURE GENETICS 13 (2006).
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guidelines, like those established by Nature Genetics, are not
always enforced. The federal guidelines on ethno-racial
categories are equally problematic, but for different reasons, a
point explored in next section.
B. FEDERAL GUIDELINES ON ETHNO-RACE IN BIOMEDICAL
RESEARCH
Although life expectancy and overall health for all
Americans improved substantially in the twentieth century,
significant health disparities remained, especially among racial
and ethnic minority communities. 178 As a result, in 1998
President Clinton proposed a twelve-year plan to end health
disparities in six areas. 179 The Clinton effort was one of many
national attempts to address health disparities among
Americans. 180 Similar efforts continue to this day, as the
National Institute on Minority Health and Health Disparities
(NIMHD) “leads, coordinates, supports and assesses the NIH
178. David Satcher, Our Commitment to Eliminate Racial and Ethnic
Health Disparities, 1 YALE J. HEALTH POL’Y L. & ETHICS 1, 1 (2001).
179. Id. at 2 (“President Clinton committed . . . to eliminate the disparities
experienced by racial and ethic minority populations in six health-related
areas, including cancer screening and management, cardiovascular disease,
diabetes, HIV/AIDS, immunization rates, and infant mortality.”).
180. Id. (“Clinton’s goal parallel[ed] the focus of Healthy People 2010—the
nation’s health objectives for the twenty-first century—which Donna Shalala,
former Secretary of the U.S. Department of Health and Human Services
(DHHS) . . . released in January 2000.”). In 1986, the Office of Minority Health
(OMH) was created to “improve health and healthcare outcomes for racial and
ethnic minority communities by developing or advancing policies, programs,
and practices that address health, social, economic, environmental and other
factors which impact health.” About OMH, The OFFICE OF MINORITY HEALTH,
http://minorityhealth.hhs.gov/templates/browse.aspx?lvl=1&lvlID=7
(last
visited Mar. 2, 2011); see also Jeffrey Brainard, Debate Over Improving
Minority Health Pits NIH Director Against Black Leaders, CHRON. HIGHER
EDUC., Sept. 10, 1999, at A41. In 1992 the Office of Research on Minority
Health (ORMH) unveiled the Minority Health Initiative (MHI), consisting of a
multi-year biomedical and behavioral research and research training program
designed to “improve prenatal health and reduce infant mortality,” fund
“studies of childhood and adolescent lead poisoning, HIV infection and AIDS,
and alcohol and drug abuse,” conduct “research in adult populations focused
on cancer, diabetes, obesity, hypertension, cardiovascular diseases, mental
disorders, asthma, visual impairments, and alcohol abuse,” and train “faculty
and . . . students at all stages of the educational pipeline.” Press Release, Nat’l
Insts. of Health, Office of Research on Minority Health (Apr. 14, 2000),
available at http://www.nih.gov/news/pr/apr2000/od-14.htm; The NIH
INSTS.
OF
HEALTH,
Almanac,
NAT’L
http://www.nih.gov/about/almanac/organization/NIMHD.htm (last visited Dec.
17, 2010).
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research effort to reduce and ultimately eliminate health
disparities” as they affect racial and ethnic communities and
medically underserved individuals. 181
Unfortunately, these well-intended legislative attempts to
encourage greater study of minority health send confusing
signals to researchers. As Dorothy Roberts points out, the
federal funding guidelines create a paradox: guideline
measures designed to remedy past discrimination and
exclusion in biomedical research based on ethno-racial labels
actually require race consciousness. 182 This form of raceconsciousness, however, risks “reinforcing biological definitions
of race that have historically legitimized racial inequalities.” 183
Thus, then-U.S. Surgeon General Dr. David Satcher, a black
physician, had to remind readers in the supplement to a
comprehensive 1999 federal report on mental health that the
term “race” as used in that report referred to “social
characteristics held in common, such as general societal
treatment and access to resources,” and not purported

181. The NIH Almanac, supra note 180. The Institute was, until recently,
the National Center on Minority Health and Health Disparities. See Press
Release, Nat’l Insts. of Health, NIH Announces Institute on Minority Health
and
Health
Disparities
(Sept.
27,
2010),
available
at
http://www.nih.gov/news/health/sep2010/nimhd-27.htm. The NIH has several
programs engaged in “medical research concerning racial and ethnic
minorities” including: the NCMHD which “leads, coordinates, supports and
assesses the NIH effort to reduce and ultimately eliminate health disparities”;
Centers for Population Health and Health Disparities, “designed to support
research to understand and reduce differences in health outcomes, access and
care”; NIH’s National Health Lung and Blood Institute (NHLBI), which
“partners with African American communities through Enhanced
Dissemination and Utilization Centers to implement education and
intervention programs to cut the rates of CVD risk factors and to promote
healthy lifestyles.” NHLBI is also conducting the Jackson Heart Study C the
first large-scale cardiovascular disease study among African Americans to
examine the factors that influence the diseases development in this
population. The National Institute of Environmental Health Sciences (NIEHS)
which is “a leader in the area of understanding how poverty, environmental
pollution, and health interrelate.” Press Release, U.S. Dep’t of Health &
Human Servs., Protecting the Health of Minority Communities (Jan. 13,
2006), available at http://www.hhs.gov/news/factsheet/minorityhealth.html.
For further information on these and other environmental health programs of
NIEHS
and
NIMH,
visit
http://www.niehs.nih.gov/.
and
http://www.nimhd.nih.gov/.
182. Roberts, supra note 17, at 528.
183. Id.
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biological differences. 184
Federal grant application regulations establish guidelines
and provide incentives for the inclusion of different racial and
ethnic groups in clinical trials. 185 But these guidelines also
create confusion. Section 5.8 of the Application Guide for NIH
and Other Public Health Services (PHS) Agencies, for example,
explains the inclusion guidelines for federally funded
studies. 186 Under this provision, studies funded by these
federal agencies are required to “identify research subjects by
race and ethnicity, to include minorities in clinical trials, and . .
. report their findings according to the racial and ethnic
identity of research subjects” 187 using OMB’s concededly
socially constructed standards, which contain five racial and
two ethnic categories. 188
These guidelines, however, seem to ignore OMB’s own
caveat that “the racial and ethnic categories set forth in the
standards should not be interpreted as being primarily
biological or genetic in reference.” 189 Moreover, federal
databases confuse racial and ethnic categories in genetic
research because samples are organized into categories that
overlap and/or conflate notions of race, ethnicity, nationality,
continental geography, and religion. 190 Mindful that OMB’s
categories are overly broad, NIH encourages reporting on

184. Matt Boucher, Turning a Blind (White) Eye in Legislating Mental
Health Parity: The Unmet, Overlooked Needs of the Working Poor in Racial
and Ethnic Minority Communities, 19 J. CONTEMP. HEALTH L. & POL’Y 465,
466 n.5 (2003) (citing U.S. DEP’T OF HEALTH & HUMAN SERVS., MENTAL
HEALTH: CULTURE, RACE, AND ETHNICITY: A SUPPLEMENT TO MENTAL
HEALTH: A REPORT OF THE SURGEON GENERAL 9 (2001) [hereinafter MHCRE]
(defining ethnicity as “a common heritage shared by a particular group”)).
Boucher’s report “uses the term ‘minority’ to ‘signify [a] group[‘s] limited
political power and social resources, as well as their unequal access to
opportunities, social rewards, and social status.” Boucher, supra, at 471 n.31
(citing MHCRE, supra, at 5).
185. Jonathan Kahn, Genes, Race, and Population: Avoiding a Collision of
Categories, 96 AM. J. PUB. HEALTH 1965, 1966 (2006).
186. See U.S. DEP’T OF HEALTH & HUM. SERVS., PUBLIC HEALTH SERVICE
GRANT APPLICATION INSTRUCTIONS § 5.8 (June 2009), available at
http://grants.nih.gov/grants/funding/phs398/phs398.pdf.
187. Roberts, supra note 17, at 529. Roberts also argues that state laws are
another potential source of regulation. Id. at 530.
188. For a critique of the OMB’s standards for reporting race and ethnic
statistics, see Response to OMB Directive 15, supra note 76.
189. Kahn, Genes, Race, and Population, supra note 185, at 1968.
190. Id. at 1966–67.
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ethno-racial categories in greater detail. 191 In determining
ethno-race, NIH also advises researchers to use subject selfidentification, 192 which, as this article previously argued, is
problematic. 193
In addition to the inadequate descriptive racial categories,
NIH’s enforcement mechanisms are not particularly helpful
because they focus on problems that arise after the research
project has received funding. 194 Continuation of the grant and
disbursement of the award depend on the submission of
periodic reports that must disclose the race and ethnicity of
human subjects. 195 This system of oversight seems to give NIH
the ability to impose funding restrictions on studies that are
not following the inclusion guidelines as mandated by federal
law.
But the inappropriate use of ethno-race usually appears at
the grant application stage in the research protocol. Further,
the follow-up to determine whether researchers complied with

191. U.S. DEP’T OF HEALTH & HUM. SERVS., GRANT APPLICATION
INSTRUCTIONS, supra note 186, at II-20 (“Subpopulations: Each ethnic/racial
group contains subpopulations that are delimited by geographic origins,
national origins, and/or cultural differences. It is recognized that there are
different ways of defining and reporting racial and ethnic subpopulation data.
The subpopulation to which an individual is assigned depends on selfreporting of specific origins and/or cultural heritage. Attention to
subpopulations also applies to individuals who self identify with more than
one race. These ethnic/racial combinations may have biomedical, behavioral,
and/or social-cultural implications related to the scientific question under
study.”).
192. Id. The OMB also encourages self-reporting: “respondent selfidentification should be facilitated to the greatest extent possible, recognizing
that in some data collection systems observer identification is more practical.”
Recommendations From the Interagency Committee for the Review of the
Racial and Ethnic Standards to the Office of Management and Budget
Concerning Changes to the Standards for the Classification of Federal Data on
Race and Ethnicity, 62 Fed. Reg. 36,873, 36,881 (Jul. 9, 1997), available at
http://www.whitehouse.gov/sites/default/files/omb/assets/omb/fedreg/ombdir15.
pdf.
193. See supra notes 83, 122–123, and accompanying text.
194. See NIH GRANTS POLICY STATEMENT (2003), available at
http://grants1.nih.gov/grants/policy/nihgps_2003/NIHGPS_Part5.htm#_Toc546
00106 (noting that “NIH uses the project period system of funding. Under this
system, projects are programmatically approved for support in their entirety
but are funded in annual increments called budget periods.”).
195. See Final Progress Report, NIH GRANTS POLICY STATEMENT (2003),
http://grants1.nih.gov/grants/policy/nihgps_2003/NIHGPS_Part8.htm#_Toc546
00141.

2011]

FUNDING RACE AS BIOLOGY

609

their plan is not with the researchers, but with the institutes
reviewing the proposals, who are required to prepare reports
“describing the manner in which the institute has complied”
with the Revitalization Act. 196 While the NIH Policy on
Reporting Race and Ethnicity Data suggests that researchers
have to complete annual reports of the total enrollment by race,
ethnicity, and gender, it does not address the consequences if
researchers fail to comply with this requirement or identify
race inappropriately. 197
A 2006 study of adherence to federal guidelines for
reporting race, ethnicity, and sex in federally funded clinical
trials published in high impact journals in 2004 found that 67%
of the trials reported the number of black subjects and 48%
reported the number of Hispanic subjects, while only 18% of
studies reported nothing with respect to the race/ethnicity of
their subjects. 198 These studies generally did not report results
by race (which seems appropriate), and the vast majority did
not acknowledge any limitations on generalizability due to the
race or ethnicity of the subjects. 199 Further, none of the four
phase III trials provided race-specific results or addressed any
statistically significant racial/ethnic differences. 200 Despite the
lack of compliance with the guidelines, and resulting lack of
diversity among trial subjects, the vast majority of studies
generalized the results to all populations. 201 Thus, requiring
researchers to be race conscious in the selection of clinical
subjects does not necessarily translate into a reification of race
in most federally funded studies.
Another study looked at the use of racial and ethnic
terminology in genetic research, and whether the use of such

196. See NIH Guidelines on the Inclusion of Women and Minorities as
Subjects in Clinical Research, 59 Fed. Reg. 14,508, 14,510 (Mar. 28, 1994).
197. NIH Policy on Reporting Race and Ethnicity Data, NIH (Aug. 8, 2001),
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-01-053.html.
198. Geller et al., supra note 116, at 1126. The authors excluded studies
that identified no federal support. In evaluating the articles, researchers noted
whether race/ethnicity specific results were reported, whether race/ethnicity
was considered in analyzing the outcomes, and whether the trials recognized
any limitations on generalizability to broader populations based on race or
ethnicity. Follow up papers were also examined for any information relating to
race or ethnicity. Id. at 1124–25.
199. Id. at 1127.
200. Id. at 1128. The sex-specific OB-GYN studies similarly did not report
results by race or ethnicity. Id. at 1127.
201. Id. at 1130.
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terms is justified or explained when the research is
published. 202 The researchers’ concern was that using ethnoracial terms without providing definitions allows the reader to
infer definitions that may be based on negative stereotypes
that, in the context of genetic research, reinforce biological
notions of race. 203 The results indicated that race or ethnicity
terminology was used as a variable in a little more than half
(51.5%) of the 330 articles reviewed. 204 Of the remaining
articles, approximately half did not include race or ethnicity
terms at all, while the other half used racial or ethnic
terminology, but only to identify the study sample, not as a
variable. 205
Most articles neither explained nor justified the use of the
particular populations studied. 206 Significantly, only 9.1% of
articles explained how a label was given to a particular
population, a basic procedure in some journal guidelines, and
arguably “a basic, easily fulfilled requirement.” 207 The authors
note that the failure to adequately explain the basis for ethnoracial assignment “impedes constructive use of study
findings.” 208 However, as recent studies of race-related stress
discussed earlier illustrate, a more thoughtful use of ethno-race
as descriptor and ascriptor can lead researchers to look more

202. Pamela Sankar et al., Race and Ethnicity in Genetic Research 143A
AM. J. MED. GENETICS 961 (2007). The articles examined in this study show
that the issue of ensuring clarity and precision in the use of racial and ethnic
terminology still warrants attention, and “inadequate explanation of the
meaning and purpose of race and ethnicity is widespread across journals.” Id.
at 968.
203. Id. at 962.
204. Id. at 966.
205. Id.
206. Id.
207. Id.
208. Id. at 968. Unlike the NIH guidelines, the FDA guidelines do “not
address the level of participation of racial and ethnic groups in clinical trials”
nor “establish legally enforceable responsibilities.” U.S. DEP’T OF HEALTH &
HUM. SERVS., GUIDANCE FOR INDUSTRY: COLLECTION OF RACE AND ETHNICITY
DATA
IN
CLINICAL
TRIALS
2
(2005),
available
at
http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm126396.p
df. Rather, the FDA guidelines on the collection of race and ethnicity data are
actually a series of recommendations to help applicants meet the requirements
of new drug applications that require subjects to be reported by race, among
other factors. Logically then, the consequence of failing to follow FDA
guidelines, or at least failing to collect racial and ethnic data, would be the
inability to complete a new drug application process.
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critically at these categories. Nevertheless, researchers still
need effective guidelines about the use of ethno-race in
biomedical research that are imposed at the beginning of the
process.
The next section of this article offers a tentative two-step
process for regulating the use of race and ethnicity in
biomedical research that addresses concerns relating to ethnoracial inclusion in clinical studies, access to health care, and
discrimination in treatment, as well as ethno-race related
disease. The proposed two-step process for a single regulatory
scheme in federal minority health initiatives would minimize
researcher confusion and trigger re-education about the use of
ethno-race in biomedical research.
IV. PROPOSAL FOR REGULATING BIOMEDICAL
RESEARCH USING RACE/ETHNICITY
As my friend’s bone density test story illustrates, racial
identity is ambiguous, even in biomedicine. This section first
proposes a two-step regulatory scheme that addresses the
concerns raised in this article about the inappropriate use of
ethno-race in biomedical research. This proposal is then applied
to a hypothetical race-related biomedical research proposal.
A. A PROPOSED REGULATORY SCHEME
One suggestion Dorothy Roberts makes about using
funding restrictions to regulate the use of ethno-race in
biomedical research is that researchers ask themselves
questions like whether race is being defined biologically or
socially and whether membership in the racialized group
“continue[s] to affect health status, access to health care and
medical treatment” and would thus require “race-conscious
scientific investigation and legal remedies.” 209 While the focus
of these questions is sound, they do not provide enough
guidance for reviewers and researchers. Rather, the three
questions recommended by the Stanford Group are sharper,
and better suited for incorporation into NIH and other PHS
funding guidelines. 210
As mentioned previously, the Stanford Group advises

209. Roberts, supra note 17, at 531.
210. See supra notes 160–166 and accompanying text.
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researchers when considering ethno-racial categories to ask
themselves first why race or ethnicity is relevant to the study
and whether alternative approaches are more appropriate. 211
Addressing this question helps researchers focus on the real
objective of their study: whether there are differences in bone
metabolism based on lifestyle.
Ethno-racial categories, for example, may be perfectly
acceptable if researchers are assessing health services, but
even in that situation, given the varied circumstances of black,
Latino and Asian American subgroups, broad non-descriptive
terms like black, white, non-white and Asian should be
avoided. Further, ethno-racial categories may be totally
inappropriate if studying the correlation between diet and high
blood pressure. Other factors like socio-economic status,
geographical location, gender, and family medical history may
be more accurate and helpful.
A second question is how race or ethnicity will be
determined. 212 As my foregoing discussion points out, subject
self-identification as opposed to researcher identification may
be appropriate if studying access to health care or physician
bias, but unhelpful when studying the prevalence of certain
diseases or conditions like sickle cell that are more prevalent in
certain areas of the world. In that case, looking at subjects’ biogeographic ancestry might provide a more useful measure.
The third question is whether the ethno-racial categories
are variables in the research. 213 Given that ethno-race has
little if any biological basis, researchers should avoid research
protocols that use only ethno-racial categories. Thus, ethnorace should not be used as a variable outside of access to health
care and treatment.
These three questions should be threshold inquiries that
applicants must address in their request for federal funding.
High impact journals also should ask these same questions
when researchers submit their findings for publication. As a
result, there would be a check at both ends of the process with
funding and publication tied to compliance with these
guidelines.
However, the existence of funding guidelines in and of
211. Id.
212. Id.
213. Lee et al., supra note 122, at 404.2.
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themselves is not enough. As the experience with the Nature
Genetics publishing guidelines indicates, mandatory guidelines
may be no more effective than aspirational ones. Thus,
additional checks are needed.
One such additional check that should be used is a review
by a health impact assessment group (HIAG) that would be
triggered any time a grant applicant’s answers to any of the
three threshold questions raise the possibility that ethno-race
will be used as an ascriptive factor. 214 In that instance a multidisciplinary HIAG would be convened and charged with
drafting a health impact assessment (HIA) to “clarify the
expected health implications of a given action, and of any
alternatives being considered, for the population groups
affected by the proposal.” 215
An HIA is a valuable tool to protect against the misuse of
race in scientific research because it is designed “to clarify
health implications by disaggregating the determinants of
health and well-being.” 216 In addition, an HIA focuses on
informed decision-making, and as such, “attempts to identify
health inequalities that may arise from a proposal.” 217

214. Information about health impact assessments (HIAs) can be found on
the World Health Organization website. Health Impact Assessments, WORLD
HEALTH ORG., http://www.who.int/hia/en/ (last visited Dec. 17, 2010); see also
R. Quigley et al., Health Impact Assessment: International Best Principles,
ASS’N
FOR
IMPACT
ASSESSMENT
(2006),
INT’L
http://www.iaia.org/publicdocuments/special-publications/SP5.pdf
(summarizing health impact assessments).
215. Nancy Krieger et al., Assessing Health Impact Assessment:
Multidisciplinary and International Perspectives, 57 J. EPIDEMIOLOGY &
CMTY. HEALTH 659, 660 (2003) (citing the WORLD HEALTH ORGANISATION,
REGIONAL OFFICE FOR EUROPE, TECHNICAL BRIEFING: HEALTH IMPACT
ASSESSMENT—A TOOL TO INCLUDE HEALTH ON THE AGENDA OF OTHER
SECTORS (2002)).
216. Quigley et al., supra note 214, at 2. The determinants of health
include individual factors, social, environmental, and institutional factors.
INT’L FINANCE CORP., WORLD BANK GROUP, INTRODUCTION TO HEALTH
IMPACT
ASSESSMENT
7
(2009),
available
at
http://www.ifc.org/ifcext/sustainability.nsf/AttachmentsByTitle/p_HealthImpa
ctAssessment/$FILE/HealthImpact.pdf.
217. Quigley et al., supra note 214, at 2. The World Health Organization
identifies several guiding principles of HIAs, including equity, defined as
“emphasizing the desire to reduce inequity that results from avoidable
differences in the health determinants and/or health status within and
between different population groups.” Id. at 3. Another guiding principle, the
ethical use of evidence, focuses on ensuring that “the best available evidence
from different disciplines and methodologies is utilized, that all evidence is
valued, and that recommendations are developed impartially.” Id.
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Legal scholar Osagie K. Obasogie proposed a similar
impact assessment mechanism that he calls a racial impact
assessment, as a regulatory tool to prevent new biotechnologies
from advancing unsubstantiated notions of biological race. 218
Although he uses the FDA approval process as an example of
when race impact assessments would be appropriate, Obasogie
notes that this process may still be useful in other contexts. 219
The value of race impact assessments, according to Obasogie, is
the shared responsibility between “regulators, researchers,
internal review boards, and affected communities and their
representatives.” 220 My proposal expands on Obasogie’s idea,
applying it to biomedical research in general and providing a
more detailed example below of how the assessment impact
would work.
B. APPLYING THE PROPOSED STANDARD: BONE DENSITY
STUDIES REVISITED
This section explains how the two-step process I outlined in
the prior section might work in real life. Suppose researchers
submitted a grant proposal seeking federal funding for a study
examining whether racial differences in bone density between
blacks and whites can be explained by differences in bone
metabolism and lifestyle. 221 The researchers propose to study a
cohort of roughly equal numbers of women and men, black and
218. Obasogie, supra note 28, at 496. As an example, Obasogie proposes an
FDA advisory committee ‘as part of its review process to evaluate whether
medicines like BiDil might reinforce biological understandings of race when no
biological or genetic mechanism has been identified. OBASOGIE, GENE CARD,
supra note 24, at 47. Obasogie’s recommendation is equally workable for
biomedical research. The ultimate goal in both instances is to “increase the
dialogue between stakeholders and policymakers so as to balance competing
interests through strategic planning that promotes public good.” Id.
219. Obasogie also suggests race impact assessments in evaluating
marketing of ancestry tests and the effects of DNA forensics on certain
communities. OBASOGIE, GENE CARD, supra note 24, at 47.
220

Id. at 46.

221. For just such a study see Bruce Ettinger et al., Racial Differences in
Bone Density Between Young Adult Black and White Subjects Persist after
Adjustment for Anthropometric, Lifestyle, and Biochemical Differences, 82 J.
CLIN. ENDOCRINOLOGY & METABOLISM 429 (1997). This study was supported
in part by the National Institute of Health & Human Services. Id. The
researchers conclude that “the appearance of . . . large racial difference in
young adults cannot be attributed to persistent differences in metabolic or
lifestyle factors and supports the view that bone density differences result
from influences operating during childhood and adolescence.” Id. at 434.
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white, between the ages of 25-36 years. 222
Other than reporting ethno-race to comply with federal
regulations designed to ensure greater access to clinical trials
by ethno-racial minorities, other use of ethno-race
automatically would be suspect. 223 If ethno-racial categories
are to be used for other purposes, researchers must explain
why these categories are relevant. Thus the researchers in the
hypothetical would need to explain why race is relevant in their
study. They might justify the use of ethno-racial categories to
examine the validity of earlier studies that found differences in
bone density between whites and blacks saying that they are
trying to determine whether these differences reflect lifestyle
rather than racial differences.
As my foregoing discussion indicates, this justification
suggests that race would be used ascriptively and thus
inappropriately. At this stage, the second step of my proposal,
an HIA, would likely be triggered. HIAG members might
discuss whether the proposed use of ethno-race in the study
tends to reinforce biological understandings of race when no
biological or genetic mechanism has been identified. If so, the
HIAG members might require that the researchers reconsider
the proposed use of ethno-race or they will withhold funding
until the researchers modify their protocol so that ethno-racial
categories are eliminated or used appropriately.
Assuming the researchers can satisfactorily explain the
relevance of race in their proposed study, the next inquiry
would be how the subjects’ race would be determined for
biomedical research as opposed to federal reporting purposes.
Consider again the problem with determining the racial
classification of the clinical subject mentioned earlier who selfidentifies as Cape Verdean. This is a question Braun and her
co-authors address. 224 Their response is that this individual
defies conventional census-related racial classification for
222. Id. at 430. The researchers also excluded “for certain laboratory
abnormalities and pregnancy-related criteria . . . . breast-feeding women” and
women currently using oral contraceptives. Id.
223. As mentioned previously, federal regulations require that researchers
use a universal standard, the OMB ethno-racial categories, in reporting the
diversity of the research study subject population. The use of OMB ethnoracial categories is used in the regulations as a way of guarding against past
exclusionary practices, but these categories are insufficiently precise for
biomedical purposes, even in access to health care studies. See Braun et al.,
supra note 15, at 1424.
224. Id.
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biomedical purposes. 225 If the researchers’ proposed method for
identifying the race of clinical subjects in this case seems
inappropriate, an HIA could again be triggered at this point.
HIAG members might suggest other approaches. One
possible approach in determining the ethno-race of a clinical
subject might be to supplement the detailed subject selfidentification collected for reporting purposes with a
questionnaire to ascertain a subject’s bio-geographical ancestry.
Thus if my friend, for example, was a subject, she might selfidentify as black or African American (as opposed to black
Caribbean or black South African or Afro-Cuban or bi/multiracial). The supplemental questionnaire would ask more
detailed information about bio-geographic ancestry, where she
was raised and currently resides.
This additional information would help separate recent
immigrants from native-born Americans, perhaps an important
variable in some studies and would naturally lead to an
examination of the answer to the third question, whether
ethno-race is used as a variable in the research. Under the
Stanford Group standard, ethno-race should not be used as a
variable outside of studies of access to health care and
treatment. 226 Thus if the research protocol indicates that
research would be used in another context, this as well would
trigger an HIA.
Concededly an HIA inquiry can be a costly and laborintensive mechanism to protect against the inappropriate use
of ethno-race in biomedical research. But without rigorous
guidelines like the ones I propose, researchers will continue “to
use these same variables in the subsequent analysis and
theoretical framing of the research.” 227 Hopefully, HIA
inquiries will be temporary measures that can be useful in
helping federal funding agencies develop more substantial
guidelines as they gain more experience reviewing individual
protocols.
It must again be noted, however, that better federal
guidelines alone will be insufficient to remedy the problem I
225. “In clinical research projects or in the clinic, the assignment of race
assumes an equivalence between census categories and genetics embodied by
patients. . . . We suggest that, as with Cape Verdeans, census race cannot be
assumed to reflect a particular genetic make-up.” Id.
226. Lee et al. supra note 122, at 404.2.
227. Braun et al., supra note 15, at 1424.
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have described. My suggestions are just a first step in changing
the way the medical community thinks about ethno-race. The
importance of better biology education, starting in high school,
is also essential in addressing the tendency to misuse ethnorace in biomedical research. 228
V. CONCLUSION
It is clear that changing how medical research
communities think about race will be difficult. Researchers,
many of whom are affiliated with medical schools, continue to
use outdated and inaccurate notions about the validity of racial
and ethnic differences in medical research unrelated to
healthcare access and provider treatment bias. These
researchers transmit their biases to their students replicating
the problematic use of ethno-race in medical research and
practice.
As my friend’s experience with her bone density test
illustrates, health care providers, like biomedical researchers,
also continue to rely, often unthinkingly, on socially
constructed racial categories in treatment and diagnosis, often
to the detriment of ethnic and racial minorities. 229 I know this
from personal experience. In 1983 my daughter’s pediatrician
suspected she had Crohn’s Disease and required
hospitalization. But upon her admission to Texas Children’s
Hospital in Houston the pediatric gastroenterologist, one of the
best in the nation, resisted this diagnosis, telling me that
Crohn’s Disease was found in “middle-class Jewish children,”
not black children. It took ten days of testing before the
gastroenterologist agreed with the pediatrician’s initial
diagnosis.
It is important to determine the validity of ethno-racial
228. Braun and her co-authors write:
Improved medical training about race can sharpen diagnostic skills.
Cultural competency instruction should be modified to include
information on the history of racial categories, current controversies
about their biological significance, and the limits of their utility. A
teaching unit on race would also contrast the differences between race
as a population concept with its meaning when applied to the lives of
individuals. In this context it would be appropriate to teach about
geographical variations in specific allele frequencies for genes linked
to particular disease processes, as well as the cultural practices,
historical trends, and environmental conditions that favor their
prevalence or not.
Braun et al., supra note 15, at 1426–27.
229. Roberts, supra note 17, at 531.
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classifications in each setting. In medicine, as in other areas,
ethno-race is so powerful that it tends to shout, drowning out
other explanations for adverse health outcomes. As Troy Duster
explains “[t]he task is to determine how the social meaning of
race can affect biological outcomes.” 230 Mandatory funding
guidelines that require researchers to think more critically
about any proposed use of ethno-race in biomedical research is
one important mechanism government should use to discourage
inappropriate use of ethno-racial categories in biomedical
research and ultimately the medical treatment of all
Americans.

230. Troy Duster, Buried Alive: The Concept of Race in Science, CHRON.
HIGHER EDUC., Sept. 14, 2001 at B12. See also Pilar Ossorio & Troy Duster,
Race and Genetics: Controversies in Biomedical, Behavioral, and Forensic
Sciences, 60 AM. PSYCHOLOGIST 115, 116 (2005).

